<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sodium chloride preparations (saline and oral salt tablets): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sodium chloride preparations (saline and oral salt tablets): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Sodium chloride preparations (saline and oral salt tablets): Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12120" href="/d/html/12120.html" rel="external">see "Sodium chloride preparations (saline and oral salt tablets): Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="12796" href="/d/html/12796.html" rel="external">see "Sodium chloride preparations (saline and oral salt tablets): Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F221678"><span class="drugH1">Brand Names: US</span>
<ul>
<li>4-Way Saline [OTC];</li>
<li>Afrin Saline Nasal Mist [OTC];</li>
<li>Altachlore [OTC];</li>
<li>Altamist Spray [OTC];</li>
<li>Atrapro Dermal Spray;</li>
<li>Ayr Nasal Mist Allergy/Sinus [OTC];</li>
<li>Ayr Saline Nasal Drops [OTC];</li>
<li>Ayr Saline Nasal Gel [OTC];</li>
<li>Ayr Saline Nasal Neti Rinse [OTC];</li>
<li>Ayr Saline Nasal No-Drip [OTC];</li>
<li>AYR Saline Nasal Rinse [OTC];</li>
<li>Ayr Saline Nasal [OTC];</li>
<li>Ayr [OTC];</li>
<li>Baby Ayr Saline [OTC];</li>
<li>Deep Sea Nasal Spray [OTC];</li>
<li>DiaB Klenz [OTC] [DSC];</li>
<li>Entsol Nasal [OTC] [DSC];</li>
<li>HyperSal;</li>
<li>Liquivida Hydration [DSC];</li>
<li>MicroKlenz Wound Cleanser [OTC] [DSC];</li>
<li>Muro 128 [OTC];</li>
<li>Nasal Moist [OTC];</li>
<li>Nebusal;</li>
<li>Ocean Complete Sinus Rinse [OTC];</li>
<li>Ocean for Kids [OTC];</li>
<li>Ocean Nasal Spray [OTC];</li>
<li>Ocean Ultra Saline Mist [OTC];</li>
<li>Pretz Irrigation [OTC];</li>
<li>Pretz Natur Moist Nasal Spray [OTC];</li>
<li>Pretz [OTC];</li>
<li>PulmoSal;</li>
<li>RadiaKlenz [OTC] [DSC];</li>
<li>Remedy 4-in-1 Body Cleanser [OTC] [DSC];</li>
<li>Rhinaris [OTC] [DSC];</li>
<li>Safe Wash [OTC] [DSC];</li>
<li>Saline Flush ZR [DSC];</li>
<li>Saline Mist Spray [OTC];</li>
<li>Saljet Rinse [OTC];</li>
<li>Saljet [OTC];</li>
<li>Sochlor [OTC] [DSC];</li>
<li>SwabFlush Saline Flush [DSC];</li>
<li>Ultra-Klenz [OTC];</li>
<li>Wound Wash Saline [OTC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52868260"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Addipak Sodium Chloride;</li>
<li>Aquapak;</li>
<li>Ballard Unit Dose</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F221688"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Electrolyte Supplement, Parenteral;</li>
<li>
                        Genitourinary Irrigant;</li>
<li>
                        Irrigant;</li>
<li>
                        Lubricant, Ocular;</li>
<li>
                        Sodium Salt</li></ul></div>
<div class="block doa drugH1Div" id="F221680"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="700bd361-15cf-4b1c-b29f-42bc889c4b13">Bronchodilator diluent</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Bronchodilator diluent:</b>
<b>Inhalation:</b> 1 to 3 sprays (1 to 3 mL) to dilute bronchodilator solution in nebulizer before administration.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e9c27a86-5732-445c-b9d1-994903eab992">Corneal edema</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Corneal edema: </b></p>
<p style="text-indent:-2em;margin-left:4em;">Ointment: <b>Ophthalmic: </b>Apply a small amount (approximately one-fourth inch) of the ointment to the affected eye(s) every 3 or 4 hours.</p>
<p style="text-indent:-2em;margin-left:4em;">Solution: <b>Ophthalmic: </b>Instill 1 to 2 drops into affected eye(s) every 3 to 4 hours.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="df85d498-37b3-4d24-95e1-d4a9ea8cb8c0">Cystic fibrosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cystic fibrosis (off-label use):</b>
<b>Inhalation:</b> 7% hypertonic saline: 4 mL two times daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29506920','lexi-content-ref-28146603','lexi-content-ref-16421364']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29506920','lexi-content-ref-28146603','lexi-content-ref-16421364'])">Ref</a></span>). <b>Note:</b> If patients cannot tolerate 7% hypertonic saline, 3% inhaled solution may be used; refer to institutional protocols. Pretreatment with an inhaled bronchodilator is recommended to prevent potential bronchospasm (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29506920','lexi-content-ref-16421364','lexi-content-ref-9404379']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29506920','lexi-content-ref-16421364','lexi-content-ref-9404379'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e41d633f-75ca-4239-ae7b-19d1078054a2">Diabetic ketoacidosis or hyperosmolar hyperglycemic state, fluid management</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Diabetic ketoacidosis or hyperosmolar hyperglycemic state, fluid management (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Goal of fluid resuscitation is to replace fluid losses, when present, within 24 to 36 hours, with half of fluid losses being replaced within the first 8 to 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30588284','lexi-content-ref-19564476']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30588284','lexi-content-ref-19564476'])">Ref</a></span>). In patients with chronic kidney disease or congestive heart failure, replace fluids carefully and monitor closely for signs and symptoms of overreplacement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25061324']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25061324'])">Ref</a></span>). Refer to institutional protocols.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Initial fluid management:</i>
<b>IV:</b> Normal saline (<b>0.9%</b> NaCl): 15 to 20 mL/kg/hour for 1 to 2 hours (usual dose: 1 to 1.5 L/hour) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25061324','lexi-content-ref-19564476']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25061324','lexi-content-ref-19564476'])">Ref</a></span>). <b>Note:</b> In patients with hypovolemic shock, more aggressive fluid replacement may be required (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29767636','lexi-content-ref-28101605']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29767636','lexi-content-ref-28101605'])">Ref</a></span>); in euvolemic patients (eg, mild diabetic ketoacidosis [DKA]), fluid replacement is less aggressive and is guided by clinical assessment (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Hirsch.1','lexi-content-ref-19564476']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Hirsch.1','lexi-content-ref-19564476'])">Ref</a></span>). If initial serum glucose is &lt;250 mg/dL, initiate dextrose-containing IV fluids when IV insulin is started (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28924481']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28924481'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Subsequent fluid management:</i>
<b>IV:</b> Choice of fluid (normal saline [<b>0.9%</b> NaCl] or half-normal saline [<b>0.45%</b> NaCl]) is based on corrected serum sodium. Individualize rate of replacement and refer to institutional protocols; an example fluid regimen after initial hydration is 4 to 14 mL/kg/hour (usual dose: 250 to 500 mL/hour). Modify fluid replacement rate based on patient-specific factors (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25061324','lexi-content-ref-19564476']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25061324','lexi-content-ref-19564476'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Once serum glucose approaches 200 to 250 mg/dL (DKA) or 250 to 300 mg/dL (hyperosmolar hyperglycemic state [HHS]), administer dextrose-containing IV fluids at a reduced rate (eg, 150 to 250 mL/hour) until DKA or HHS has resolved (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25061324','lexi-content-ref-Hirsch.1','lexi-content-ref-19564476']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25061324','lexi-content-ref-Hirsch.1','lexi-content-ref-19564476'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="705de6bf-8c89-467b-8edd-00df82a09b07">Genitourinary irrigant</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Genitourinary irrigant:</b>
<b>Irrigation:</b> 1 to 3 L/day by intermittent irrigation.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="3badc2cd-227e-482b-a0dc-af02405146d8">Hypercalcemia, volume replacement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hypercalcemia, volume replacement (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> For use with other treatments in patients with volume depletion to restore intravascular volume and to lower serum calcium; most patients with albumin-corrected serum calcium &gt;14 mg/dL (&gt;3.5 mmol/L) will require volume replacement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Shane.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Shane.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IV:</b> Normal saline (<b>0.9%</b> NaCl): Initial: 1 to 2 L bolus (optional), followed by 150 to 300 mL/hour for 24 to 48 hours or until euvolemic; dose is highly variable and must be guided by clinical assessment. In patients without heart failure or kidney impairment, the usual dose range is ~3 to 6 L of fluids in the first 24 to 48 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27170690','lexi-content-ref-21568230','lexi-content-ref-24130250','lexi-content-ref-19570736','lexi-content-ref-Shane.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27170690','lexi-content-ref-21568230','lexi-content-ref-24130250','lexi-content-ref-19570736','lexi-content-ref-Shane.1'])">Ref</a></span>). <b>Note:</b> In patients with heart failure or kidney impairment, monitor carefully while replacing fluids (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27170690','lexi-content-ref-21568230']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27170690','lexi-content-ref-21568230'])">Ref</a></span>); cautious use of loop diuretics (after intravascular volume has been replaced) may be required to prevent fluid overload (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Shane.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Shane.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="04900754-70ce-4aca-bc02-7880270475bf">Hyponatremia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hyponatremia:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> For the correction of acute (&lt;48 hours) or chronic (≥48 hours or duration unknown) hyponatremia. Goal of initial therapy is to achieve a 24 hour increase in serum sodium concentration by 4 to 6 mEq/L (maximum serum sodium increase: 8 mEq/L in any 24-hour period), which is sufficient to improve most symptoms of hyponatremia. However, if patient is symptomatic (acute or chronic hyponatremia), it is recommended to increase serum sodium by 4 to 6 mEq/L within the first 6 hours, then maintain serum sodium at a constant level for the remainder of the 24-hour period. In chronic severe hyponatremia, overcorrection or too rapid correction increases the risk of iatrogenic osmotic demyelination syndrome (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Sterns.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Sterns.1'])">Ref</a></span>). Choice of fluid concentration for sodium correction is dependent upon the severity of the hyponatremia; use hypertonic sodium solutions (eg, 3% NaCl) for symptomatic patients; monitor serum sodium closely during therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23918113']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23918113'])">Ref</a></span>). The following recommendations are based on use of 3% NaCl:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Acute hyponatremia (serum sodium &lt;130 mEq/L):</i></p>
<p style="text-indent:-2em;margin-left:6em;">Asymptomatic:</p>
<p style="text-indent:-2em;margin-left:8em;">Hypertonic saline: <b>3%</b> NaCl:<b> IV: </b>50 mL bolus over 10 minutes; monitor serum sodium every 1 to 2 hours to assess need for additional treatment. For treatment goals, refer to "Hyponatremia: Note." <b>Note:</b> Some experts withhold hypertonic saline if hyponatremia is autocorrecting due to water diuresis (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Sterns.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Sterns.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Symptomatic:</p>
<p style="text-indent:-2em;margin-left:8em;">Hypertonic saline: <b>3%</b> NaCl: <b>IV: </b>100 mL over 10 minutes; if symptoms persist, may repeat up to a total of 3 doses over a period of 30 minutes; monitor serum sodium hourly to assess need for repeat treatment (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Sterns.1','lexi-content-ref-24074529','lexi-content-ref-32044213']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Sterns.1','lexi-content-ref-24074529','lexi-content-ref-32044213'])">Ref</a></span>). Alternatively, some experts recommend 150 mL over 20 minutes up to a total of 2 doses while measuring serum sodium between infusions (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24569125']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24569125'])">Ref</a></span>). For treatment goals, refer to "Hyponatremia: Note."</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Chronic hyponatremia (serum sodium &lt;130 mEq/L):</i></p>
<p style="text-indent:-2em;margin-left:6em;">Asymptomatic or mild to moderate symptoms, moderate hyponatremia (serum sodium 120 to 129 mEq/L):</p>
<p style="text-indent:-2em;margin-left:8em;">
<b>IV:</b> Administration of <b>3%</b> NaCl is generally not indicated; identify reason for hyponatremia and treat as appropriate (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Sterns.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Sterns.1'])">Ref</a></span>). For treatment goals, refer to "Hyponatremia: Note."</p>
<p style="text-indent:-2em;margin-left:6em;">Asymptomatic or mild to moderate symptoms, severe hyponatremia (serum sodium &lt;120 mEq/L):</p>
<p style="text-indent:-2em;margin-left:8em;">Hypertonic saline: <b>3%</b> NaCl: <b>IV: </b>Initial: 15 to 30 mL/hour with frequent serum sodium monitoring (eg, every 2 to 6 hours, depending on risk of rapid correction and/or osmotic demyelination syndrome); <b>or</b> alternatively, 1 mL/kg bolus (maximum bolus: 100 mL) over 10 minutes every 6 hours as needed (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Sterns.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Sterns.1'])">Ref</a></span>). For treatment goals, refer to "Hyponatremia: Note." <b>Note:</b> Consider combination therapy with desmopressin to prevent overcorrection in select patients (eg, high risk of developing osmotic demyelination syndrome) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23266328','lexi-content-ref-Sterns.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23266328','lexi-content-ref-Sterns.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Severe symptoms (eg, seizures, obtundation, coma, respiratory arrest) or known intracranial pathology:</p>
<p style="text-indent:-2em;margin-left:8em;">Hypertonic saline: <b>3%</b> NaCl: <b>IV: </b>100 mL over 10 minutes; if symptoms persist, may repeat up to a total of 3 doses over a period of 30 minutes (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Sterns.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Sterns.1'])">Ref</a></span>). Alternatively, some experts recommend 150 mL over 20 minutes, up to a total of 2 doses while measuring serum sodium between infusions (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24569125']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24569125'])">Ref</a></span>). For treatment goals, refer to "Hyponatremia: Note."</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1e1d0a02-3405-4641-9442-728e902ec4f5">Intracranial hypertension due to various etiologies, transtentorial herniation syndromes</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Intracranial hypertension (refractory) due to various etiologies (eg, subarachnoid hemorrhage, trauma, neoplasm), transtentorial herniation syndromes (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IV</b> (via central venous access only): Hypertonic saline: <b>23.4%</b> NaCl: 15 to 60 mL administered over 2 to 20 minutes (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-18272864','lexi-content-ref-24026522','lexi-content-ref-9635664','lexi-content-ref-16239885']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-18272864','lexi-content-ref-24026522','lexi-content-ref-9635664','lexi-content-ref-16239885'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Intraosseous:</b> Hypertonic saline: <b>23.4%</b> NaCl: 30 mL administered over 3 to 5 minutes; remove intraosseous catheter after 24 hours due to the complication risk with prolonged use (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30328363','lexi-content-ref-30397844']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30328363','lexi-content-ref-30397844'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d6adf6f0-5962-4760-aca9-9c3a56ee7bb7">Intracranial hypertension due to traumatic brain injury</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Intracranial hypertension due to traumatic brain injury (off-label use):</b>
<b>Note:</b> Optimal dose has not been established; due to insufficient evidence, the Brain Trauma Foundation guidelines do not make specific recommendations on the use of hypertonic saline for the treatment of traumatic intracranial hypertension (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27654000']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27654000'])">Ref</a></span>). Clinical trials are small; few are prospective. <b>Some concentrations may not be commercially available;</b> protocols include:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Continuous infusion: </i>
<b>IV:</b> Hypertonic saline: <b>3%</b> NaCl: Initial: 30 to 50 mL/hour; titrate to maintain serum sodium between 145 to 155 mEq/L (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28215427','lexi-content-ref-Rajajee.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28215427','lexi-content-ref-Rajajee.1'])">Ref</a></span>). May administer 23.4% bolus infusions to treat acute intracranial pressure (ICP) elevations (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Rajajee.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Rajajee.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Intermittent bolus dosing: </i>Hypertonic saline:</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>IV</b> (via central venous access only):<b> 23.4%</b> NaCl: 30 mL administered over 2 to 10 minutes as needed to treat acute ICP elevations (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19667879','lexi-content-ref-Rajajee.1','lexi-content-ref-16239885']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19667879','lexi-content-ref-Rajajee.1','lexi-content-ref-16239885'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>IV</b> (via central venous access only):<b> 7.5% </b>NaCl: 2 mL<b>/kg</b> administered over 20 minutes when ICP values exceed 25 mm Hg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-12794404']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-12794404'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Intraosseous:</b>
<b>23.4% </b>NaCl: 30 mL administered over 3 to 5 minutes for &lt;24 hours; may be administered prior to administering a 3% NaCl continuous infusion; remove intraosseous catheter after 24 hours due to the complication risk with prolonged use (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30328363','lexi-content-ref-30397844']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30328363','lexi-content-ref-30397844'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="aa6069be-77fb-4807-b092-cbf82db43773">Nasal congestion</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Nasal congestion: Intranasal:</b> 2 to 3 sprays in each nostril as needed.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d3f7203a-e10c-47ac-b028-3c148b2d3e81">Parenteral nutrition</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Chloride maintenance electrolyte requirement: </i>
<b>IV:</b> As needed to maintain acid-base balance with parenteral nutrition; use equal amounts of chloride and acetate to maintain balance and adjust ratio based on individual patient needs (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-15568296']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-15568296'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Sodium maintenance electrolyte requirement: </i>
<b>IV:</b> 1 to 2 mEq/kg/24 hours; customize amounts based on individual patient needs (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-15568296']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-15568296'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a6e76fea-ecea-4bd0-9e22-cced5898af7a">Sclerotherapy, lower-extremity venous disease</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Sclerotherapy, lower-extremity venous disease (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> May mix with local anesthetic to reduce pain during injection. The following concentrations have been recommended based upon size of affected vein (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-17966153','lexi-content-ref-22620717','lexi-content-ref-Scovell.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-17966153','lexi-content-ref-22620717','lexi-content-ref-Scovell.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IV:</b> Hypertonic saline:</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>11.7% to 15%</b> NaCl:</p>
<p style="text-indent:-2em;margin-left:8em;">Vessel diameter &lt;0.5 mm: 0.25 mL per injection.</p>
<p style="text-indent:-2em;margin-left:8em;">Vessel diameter 0.5 to 1 mm: 0.5 mL per injection.</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>15% to 23.4%</b> NaCl:</p>
<p style="text-indent:-2em;margin-left:8em;">Vessel diameter 1 to 3 mm: 0.5 to 1 mL per injection.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="51914f4b-a37f-4ff2-9a24-b66160a45f7a">Septic shock or sepsis-induced hypoperfusion, fluid resuscitation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Septic shock or sepsis-induced hypoperfusion, fluid resuscitation (off-label use): </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Balanced crystalloids may be preferred over normal saline; however, fluid therapy should be individualized (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-35041780','lexi-content-ref-31364382','lexi-content-ref-34605781']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-35041780','lexi-content-ref-31364382','lexi-content-ref-34605781'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IV:</b> Normal saline (<b>0.9%</b> NaCl): Initial resuscitation: Minimum of 30 mL/kg to be given within the first 3 hours for shock or hypoperfusion. Administer vasopressors during or after fluid resuscitation to maintain a mean arterial pressure ≥65 mmHg; following initial resuscitation, additional fluid administration guided by frequent reassessment of hemodynamic status may be necessary (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34605781']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34605781'])">Ref</a></span>). <b>Note:</b> Some patients may require more rapid administration and/or greater amount of fluid for complete initial resuscitation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34605781','lexi-content-ref-28101605']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34605781','lexi-content-ref-28101605'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="3214ab6d-de68-4179-8541-e4c839a867b9">Subarachnoid hemorrhage with hyponatremia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Subarachnoid hemorrhage with hyponatremia (ie, ≤133 mEq/L or a decrease by ≥</b>
<b>6 mEq/L over 24 to 48 hours) (off-label use): </b>
<b>IV:</b> Hypertonic saline: <b>3%</b> NaCl: Initial: 20 mL/hour; titrate by increasing rate by 10 to 20 mL/hour to maintain serum sodium between 136 to 140 mEq/L; may also administer concurrently with oral sodium chloride (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19533046']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19533046'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0c4a79d9-9a4a-4c57-b630-ef6d0dd28005">Wound irrigation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Wound irrigation:</b> Spray affected area.</p></div>
</div>
</div>
<div class="block doe drugH1Div" id="F221681"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F221684"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="12796" href="/d/html/12796.html" rel="external">see "Sodium chloride preparations (saline and oral salt tablets): Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Systemic hypertonic solutions (&gt;0.9%) should only be used for the initial treatment of acute serious symptomatic hyponatremia or increased intracranial pressure.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Normal daily maintenance sodium requirements</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Corkins.1','lexi-content-ref-15568296']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Corkins.1','lexi-content-ref-15568296'])">Ref</a></span>):</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Consider all sources of sodium when calculating patient needs; daily maintenance sodium requirements can be met with a combination or enteral and parenteral sources (eg, enteral formulas, IV solutions, parenteral nutrition). Maintenance sodium should be incorporated into the patient's maintenance IV fluids; acid/base balance should be considered when selecting a sodium salt; individualize dose based on patient requirements.</p>
<p style="text-indent:-2em;margin-left:4em;">Infants and Children ≤50 kg: Oral, IV: 2 to 5 mEq/kg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Children &gt;50 kg and Adolescents: Oral, IV: 1 to 2 mEq/kg/day.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="04900754-70ce-4aca-bc02-7880270475bf">Hyponatremia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hyponatremia:</b> Infants, Children, and Adolescents: IV: <b>Note: </b>The choice of saline preparation (eg, <b>0.9% isotonic solution</b> or <b>3% hypertonic solution</b>) is based on the presence and severity of symptoms. The use of <b>3% hypertonic solution</b> is generally limited to symptomatic patients (severe hyponatremia) with neurologic findings (eg, seizures, altered mental status) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Schmidt.1','lexi-content-ref-Bruno.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Schmidt.1','lexi-content-ref-Bruno.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Symptomatic (severe hyponatremia with severe neurologic symptoms)</i>: Limited data available; variable regimens reported: <b>3% hypertonic solution:</b> Bolus IV infusion: 2 to 5 mL/kg over 20 minutes (maximum dose: 150 mL/dose); monitor serum sodium 20 minutes after dose. If necessary, may repeat up to 2 times if severe symptoms continue (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bruno.1','lexi-content-ref-23283268']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bruno.1','lexi-content-ref-23283268'])">Ref</a></span>). Alternatively, dosing can be based on the estimation of the sodium deficit* needed to correct the serum sodium by 4 to 6 mEq/L in the initial 1 to 4 hours of symptom onset. Maximum correction rate: 0.5 mEq/L/hour or 10 mEq/L/<b>24 hours</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Schmidt.1','lexi-content-ref-Bruno.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Schmidt.1','lexi-content-ref-Bruno.1'])">Ref</a></span>). In cases in which the onset of hyponatremia has been sudden (&lt;24 hours), the rate of correction can match the rate of onset without an mEq/L/hour limit. <b>Note:</b> Continuous infusion of hypertonic saline may be considered, consult institutional policy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bruno.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bruno.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Asymptomatic or mild to moderate symptoms (mild to moderate hyponatremia): </i>Limited data available: <b>Note:</b> Dosing based on estimation of the sodium deficit* with replacement using <b>0.9 % isotonic solution </b>over 24 to 48 hours. In general, no more than 50% of sodium deficit should be replaced over 12 hours. Maximum correction rate: 8 mEq/<b>24 hours </b>(chronic hyponatremia duration &gt;48 hours) or 10 mEq/<b>24 hours </b>(acute hyponatremia duration &lt;48 hours) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Schmidt.1','lexi-content-ref-Bruno.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Schmidt.1','lexi-content-ref-Bruno.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">*Sodium deficit (mEq sodium) = [desired serum sodium (mEq/L) - actual serum sodium (mEq/L)] x 0.6 x wt (kg)</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="32c486e4-28fd-4bdc-870a-d8f00a1183e8">Hypovolemic shock</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hypovolemic shock:</b> Infants, Children, and Adolescents: IV: <b>0.9% isotonic solution:</b> 20 mL/kg/dose; may repeat until blood pressure and markers of cardiac output (eg, capillary refill, heart rate, peripheral pulses) improve or until signs of fluid overload occur; usual requirement is 40 to 60 mL/kg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28509730']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28509730'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ee0087ef-8466-4102-b2bc-5512e37fa0e6">Septic shock</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Septic shock:</b> Limited data available: Infants, Children, and Adolescents: IV: <b>0.9% isotonic solution:</b> 10 to 20 mL/kg/dose; maximum dose: 1,000 mL/dose; repeat every 15 minutes for up to 4 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30087153','lexi-content-ref-33081526']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30087153','lexi-content-ref-33081526'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a00a5717-ca68-4e2a-9b15-248f3f888028">Cerebral edema, diabetic ketoacidosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cerebral edema, diabetic ketoacidosis:</b> Limited data available: Infants, Children, and Adolescents: <b>3% hypertonic solution:</b> IV: 2.5 to 5 mL/kg administered over 10 to 15 minutes, can be used as an alternative to mannitol or in those unresponsive to mannitol (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23283268','lexi-content-ref-29900641']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23283268','lexi-content-ref-29900641'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="287bc14f-917d-4752-9049-9ba7a816b88f">Increased intracranial pressure, traumatic brain injury</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Increased intracranial pressure (ICP), traumatic brain injury (TBI):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Monitor sodium concentration closely, avoid sustained (&gt;72 hours) serum sodium concentrations &gt;170 mEq/L to avoid thrombocytopenia and anemia and avoid serum sodium concentrations &gt;160 mEq/L to avoid deep vein thrombosis (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30829890']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30829890'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Bolus: Limited data available; dosing regimens variable: Infants, Children, and Adolescents: <b>3% hypertonic solution: </b> IV: 2 to 5 mL/kg administered over 10 to 20 minutes (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23283268','lexi-content-ref-30829890','lexi-content-ref-26673840']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23283268','lexi-content-ref-30829890','lexi-content-ref-26673840'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Continuous IV infusion: Infants, Children, and Adolescents: <b>3% hypertonic solution:</b> IV infusion: 0.1 to 1 mL/kg/hour titrated to maintain ICP &lt;20 mm Hg (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30829890']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30829890'])">Ref</a></span>); monitor serum sodium concentration closely.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ec8f880b-1bd7-4a75-a255-42466902fae6">Refractory increased intracranial pressure, traumatic brain injury</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Refractory increased intracranial pressure (ICP), traumatic brain injury (TBI):</b> Limited data available: <b>23.4% hypertonic solution:</b> Infants, Children, and Adolescents: IV: 0.5 mL/kg. Maximum dose: 30 mL/dose. <b>Note:</b> Therapy should not be administered to patients with a serum sodium &gt;155 mEq/L (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30829890']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30829890'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c317c769-eed9-4542-b8c5-c3198e7278b4">Bronchiolitis, viral</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Bronchiolitis, viral (mild to moderate, inpatient):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Current bronchiolitis guidelines do not recommend hypertonic saline to treat infants in the emergency department; however, it may be administered to hospitalized infants and children (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25349312']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25349312'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants and Children &lt;18 months: Limited data available, efficacy results variable, optimal dose not defined: Inhalation: <b>3% solution:</b> 4 mL inhaled every 2 hours for 3 doses followed by every 4 hours for 5 doses and continued every 6 hours until discharge (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-17719935']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-17719935'])">Ref</a></span>). Other trials using doses of 2 to 4 mL every 6 hours have shown no benefit (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25389139','lexi-content-ref-26334188','lexi-content-ref-29327810','lexi-content-ref-26553190']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25389139','lexi-content-ref-26334188','lexi-content-ref-29327810','lexi-content-ref-26553190'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="df85d498-37b3-4d24-95e1-d4a9ea8cb8c0">Cystic fibrosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cystic fibrosis (CF):</b> Children ≥2 years and Adolescents: <b>7</b>
<b>% solution:</b> Inhalation: 4 mL inhaled twice daily; pretreatment with an inhaled bronchodilator is recommended to prevent potential bronchospasm (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-20435858','lexi-content-ref-16421364','lexi-content-ref-27009033','lexi-content-ref-23540878','lexi-content-ref-31178421','lexi-content-ref-22610452']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-20435858','lexi-content-ref-16421364','lexi-content-ref-27009033','lexi-content-ref-23540878','lexi-content-ref-31178421','lexi-content-ref-22610452'])">Ref</a></span>). May be considered for use in symptomatic infants &lt;2 years of age (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19914445']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19914445'])">Ref</a></span>). <b>Note:</b> Clinically, some CF centers use 3% or 3.5% inhaled solutions if patients cannot tolerate 7%.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ba02eba9-ea41-49f9-88d7-feee0c0c2144">Nasal dryness/congestion</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Nasal dryness/congestion:</b>
<b>Note:</b> Consult product-specific labeling for approved use in pediatric patients; available concentrations vary. Intranasal solution:</p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents: Intranasal: 2 to 6 drops per nostril as needed. Product concentrations vary; most are a 0.65% to 0.9% solution.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e9c27a86-5732-445c-b9d1-994903eab992">Corneal edema</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Corneal edema:</b> Infants, Children, and Adolescents: Ophthalmic:</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic ointment (5%): Apply small amount (<sup>1</sup>/<sub>4</sub> inch) every 3 to 4 hours as needed.</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic solution (5%): Instill 1 to 2 drops into affected eye(s) every 3 to 4 hours as needed.</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F221657"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions are derived from product labeling unless otherwise specified. Reported adverse reactions are for IV (hypertonic, hypotonic, isotonic) solutions.</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Acid-base imbalance (including hyperchloremic metabolic acidosis, metabolic acidosis) (Finfer 2022, Lobo 2012, Semler 2016), electrolyte disorder (including hyperchloremia, hyperkalemia) (Finfer 2022, Lobo 2012, Semler 2016), hypernatremia (Van De Louw 2014), hyponatremia</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Disorder of hemostatic components of blood (Chang 2016)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Infusion-related reaction (Meng 2018)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Localized phlebitis (Meng 2018)</p>
<p style="text-indent:-2em;margin-left:4em;">Renal: Acute kidney injury (Semler 2016), decreased estimated GFR (eGFR) (Semler 2016), decreased renal blood flow (Semler 2016), renal failure syndrome (Shaw 2012)</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Inflammation (increased inflammatory markers) (Chang 2016)</p></div>
<div class="block coi drugH1Div" id="F221671"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to sodium chloride or any component of the formulation; hypernatremia and/or fluid retention (dosage form specific).</p></div>
<div class="block war drugH1Div" id="F221654"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Extravasation: Concentrated solutions of IV sodium chloride (&gt;1%) are irritants (with vesicant-like properties at higher osmolarities); depends on osmolarity; higher osmolarity is associated with a higher risk. Ensure proper needle or catheter placement prior to and during infusion. Avoid extravasation.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hemolysis: The use of hypotonic saline solutions (eg, sodium chloride 0.225%) may result in hemolysis if administered rapidly and for prolonged periods. If hypotonic saline solutions become necessary, administration as D5W/NaCl 0.2% or NaCl 0.45% is recommended for most patients (eg, those without hyperglycemia).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Cirrhosis: Use with caution in patients with cirrhosis.</p>
<p style="text-indent:-2em;margin-left:4em;">• Edema: Use with caution in patients with edema.</p>
<p style="text-indent:-2em;margin-left:4em;">• Heart failure: Use with caution in patients with heart failure.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hypertension: Use with caution in patients with hypertension.</p>
<p style="text-indent:-2em;margin-left:4em;">• Kidney impairment: Use with caution in patients with kidney impairment; may cause sodium retention.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Bacteriostatic sodium chloride contains benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Intravenous: Use caution when choosing from the available parenteral preparations; errors have occurred with choosing the wrong concentration and significant patient harm has occurred upon administration.</p>
<p style="text-indent:-2em;margin-left:4em;">• Irrigants: For external use only; not for parenteral use. Do not use during electrosurgical procedures. Irrigating fluids may be absorbed into systemic circulation; monitor for fluid or solute overload.</p>
<p style="text-indent:-2em;margin-left:4em;">• Wound Wash Saline: For single-patient use only.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878633"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">In neonates, maximum serum concentration correction rate should generally not exceed 10 mEq/L/day; in infants, children, adolescents, and adults, do not exceed a maximum serum concentration correction rate of 12 mEq/L/day. Administration of low sodium or sodium free IV solutions may result in significant hyponatremia or water intoxication in pediatric patients; monitor serum sodium concentration.</p>
<p style="text-indent:0em;margin-top:2em;">Some dosage forms may contain propylene glycol; in neonates, large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block dosfc drugH1Div" id="F21963631"><span class="drugH1">Dosage Forms Considerations</span>
<p style="text-indent:0em;display:inline">1 g sodium chloride = elemental sodium 393.3 mg = 17.1 mEq sodium = sodium 17.1 mmol</p></div>
<div class="block foc drugH1Div" id="F2016668"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Aerosol Solution, Nasal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ocean Complete Sinus Rinse:  (177 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Aerosol Solution, Nasal [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ocean Complete Sinus Rinse:  (177 mL) [drug free]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, Nasal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ayr Saline Nasal:  (14.1 g) [contains aloe barbadensis miller, fd&amp;c blue #1 (brilliant blue), methylparaben, propylparaben, soybean oil]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ayr Saline Nasal No-Drip:  (22 mL) [contains aloe barbadensis miller, benzalkonium chloride, benzyl alcohol, soybean oil]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Kit, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Liquivida Hydration: 0.9% [DSC]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Liquid, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Atrapro Dermal Spray:  (236 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">DiaB Klenz:  (240 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">MicroKlenz Wound Cleanser:  (240 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">RadiaKlenz:  (240 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Remedy 4-in-1 Body Cleanser: 0.5% (236 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ultra-Klenz:  (240 mL, 360 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Nebulization Solution, Inhalation: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (3 mL); 3% (4 mL); 7% (4 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Nebulization Solution, Inhalation [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">HyperSal: 3.5% (4 mL) [latex free]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">HyperSal: 7% (4 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Nebusal: 3% (4 mL); 6% (4 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">PulmoSal: 7% (4 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (3 mL, 5 mL, 15 mL); 3% (4 mL, 15 mL); 7% (4 mL); 10% (4 mL, 15 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Ointment, Ophthalmic: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Altachlore: 5% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Muro 128: 5% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 5% (3.5 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Packet, Nasal [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ayr Saline Nasal Neti Rinse: Sodium chloride and sodium bicarbonate (40 ea) [iodine free]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">AYR Saline Nasal Rinse: Sodium chloride and sodium bicarbonate (50 ea, 51 ea, 100 ea) [iodine free]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Saljet: 0.9% (30 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Wound Wash Saline: 0.9% (210 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Safe Wash: 0.9% (210 mL [DSC]) [drug free, latex free]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Saljet Rinse: 0.9% (30 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Injection: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (2 mL, 10 mL, 20 mL, 30 mL, 100 mL); 14.6% (20 mL, 40 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Injection [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (2 mL, 3 mL [DSC], 5 mL [DSC], 10 mL, 20 mL, 50 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">SwabFlush Saline Flush: 0.9% (10 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.45% (50 mL, 100 mL, 250 mL, 500 mL, 1000 mL); 0.9% (10 mL [DSC], 25 mL, 50 mL, 100 mL, 250 mL, 500 mL, 1000 mL); 3% (500 mL); 5% (500 mL); 23.4% (30 mL, 100 mL, 200 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Saline Flush ZR: 0.9% (2.5 mL [DSC], 5 mL [DSC], 10 mL [DSC]) [latex free]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.45% (50 mL, 100 mL, 250 mL, 500 mL, 1000 mL); 0.9% (1 mL, 2 mL, 2.5 mL, 3 mL, 5 mL, 10 mL, 25 mL, 50 mL, 100 mL, 125 mL, 150 mL, 250 mL, 500 mL, 1000 mL); 3% (500 mL); 23.4% (30 mL [DSC], 200 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Irrigation: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (100 mL [DSC], 120 mL [DSC], 250 mL, 500 mL, 1000 mL, 1500 mL, 2000 mL, 3000 mL, 4000 mL [DSC], 5000 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Nasal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4-Way Saline:  (29.6 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Afrin Saline Nasal Mist: 0.65% (30 mL, 45 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Altamist Spray: 0.65% (45 mL, 60 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ayr: 0.65% (50 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ayr Nasal Mist Allergy/Sinus: 2.65% (50 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ayr Saline Nasal Drops: 0.65% (50 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Baby Ayr Saline: 0.65% (30 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Deep Sea Nasal Spray: 0.65% (44 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Nasal Moist: 0.65% (15 mL, 45 mL) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ocean for Kids: 0.65% (37.5 mL) [alcohol free, drug free; contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ocean for Kids: 0.65% (37.5 mL) [drug free; contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ocean Nasal Spray: 0.65% (44 mL, 45 mL, 66 mL, 104 mL, 480 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pretz:  (50 mL, 946 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pretz Irrigation:  (237 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Rhinaris: 0.2% (30 mL [DSC]) [contains benzalkonium chloride, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Saline Mist Spray: 0.65% (44 mL) [contains benzalkonium chloride]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.65% (44 mL, 88 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Nasal [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Entsol Nasal: 3% (100 mL [DSC]) [drug free]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ocean Ultra Saline Mist:  (90 mL) [drug free]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Pretz Natur Moist Nasal Spray:  (20 mL) [cfc free]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Ophthalmic: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Altachlore: 5% (15 mL, 30 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Muro 128: 2% (15 mL); 5% (15 mL, 30 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Sochlor: 5% (15 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 5% (15 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 4 mEq/mL (23.4%) (473 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Swab, Nasal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ayr Saline Nasal Gel:  (20 ea) [contains methylparaben, propylparaben, soybean oil, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1 g</p></div>
<div class="block geq drugH1Div" id="F221650"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F221673"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Nebulization</b> (HyperSal Inhalation)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3.5% (per mL): $0.22</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">7% (per mL): $0.22</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Nebulization</b> (Nebusal Inhalation)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3% (per mL): $0.19</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">6% (per mL): $0.20</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Nebulization</b> (PulmoSal Inhalation)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">7% (per mL): $0.20</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Nebulization</b> (Sodium Chloride Inhalation)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.10 - $0.14</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3% (per mL): $0.20 - $0.21</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">7% (per mL): $0.08 - $0.21</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10% (per mL): $0.10</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Altachlore Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (per gram): $3.89</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Muro 128 Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (per gram): $4.22</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Sodium Chloride (Hypertonic) Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (per gram): $3.09 - $3.52</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Pack</b> (Ayr Saline Nasal Neti Rinse Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.57 g (per each): $0.20</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Pack</b> (AYR Saline Nasal Rinse Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.57 g (per each): $0.08</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Afrin Saline Nasal Mist Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.65% (per mL): $0.09</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Altachlore Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (per mL): $1.16</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ayr Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.65% (per mL): $0.05</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ayr Nasal Mist Allergy/Sinus Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.65% (per mL): $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ayr Saline Nasal Drops Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.65% (per mL): $0.05</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Baby Ayr Saline Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.65% (per mL): $0.08</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Muro 128 Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2% (per mL): $1.21</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (per mL): $1.28</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Nasal Moist Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.65% (per mL): $0.16</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ocean for Kids Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.65% (per mL): $0.08</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ocean Nasal Spray Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.65% (per mL): $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Saline Bacteriostatic Injection)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.11</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Saline Nasal Spray Nasal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.65% (per mL): $0.04</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Saljet External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Saljet Rinse External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Sodium Chloride (Hypertonic) Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (per mL): $0.35 - $0.70</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Sodium Chloride (PF) Injection)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.11 - $4.70</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Sodium Chloride Flush Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.06 - $0.15</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Sodium Chloride Injection)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5 mEq/mL (per mL): $0.11 - $0.23</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Sodium Chloride Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.45% (per mL): $0.01 - $0.02</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.02 - $0.32</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3% (per mL): $0.01 - $0.02</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4 mEq/mL (per mL): $0.09 - $0.16</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (per mL): $0.01 - $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Sodium Chloride Irrigation)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.00 - $0.12</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Sodium Chloride Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">4 mEq/mL (per mL): $0.12 - $0.15</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Wound Wash Saline External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.9% (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Sodium Chloride Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1 g (per each): $0.03 - $0.29</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52868261"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Nebulization Solution, Inhalation: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Addipak Sodium Chloride: 0.9% (3 mL, 5 mL, 15 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Aquapak: 0.9% (150 mL, 760 mL, 1070 mL, 2200 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (15 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Injection: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (10 mL, 20 mL, 30 mL, 50 mL, 100 mL, 250 mL, 500 mL, 1000 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.45% (500 mL, 1000 mL); 0.9% (10 mL, 20 mL, 25 mL, 50 mL, 100 mL, 150 mL, 250 mL, 500 mL, 1000 mL); 3% (250 mL, 500 mL); 5% (500 mL); 20% (500 mL); 23.4% (5 mL, 30 mL, 50 mL, 100 mL, 200 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Irrigation: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.9% (500 mL, 1000 mL, 3000 mL)</p></div>
<div class="block adm drugH1Div" id="F4052605"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Ophthalmic:</b> Ophthalmic solution, ointment: Do not touch tip of container to any surface to avoid contamination. Replace cap after use. Do not use solution if the solution color changes or becomes cloudy. Do not use ointment if it is difficult to dispense or if particles are seen in the product. Apply ointment to the inside of the eyelid by first pulling down the lower lid of the affected eye.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral inhalation:</b> Nebulization solution: Compatibility with other medications (eg, budesonide) in nebulizer has been reported; also refer to institution-specific policies (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24172851']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24172851'])">Ref</a></span>). Refer to manufacturer's labeling for additional administration information.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b> Irrigation solution: Do not warm &gt;66°C (150°F); not for IV use. Wound Wash Saline: Before use, expel a short stream into air to clear nozzle.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Intraosseous:</b> &gt;2% solutions: Based on data in adult patients, intraosseous administration is a reasonable alternative when quick IV access is not feasible (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28913634','lexi-content-ref-30328363','lexi-content-ref-30397844']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28913634','lexi-content-ref-30328363','lexi-content-ref-30397844'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>IV:</b></p>
<p style="text-indent:-2em;margin-left:4em;">&gt;2% solutions: Administration through a central venous line is recommended due to high osmolarity and tonicity (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-16817665']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-16817665'])">Ref</a></span>). In the absence of a central line and when urgent administration is necessary, 3% solutions may be safely administered through a peripheral venous line (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28372499','lexi-content-ref-27965228','lexi-content-ref-29472509','lexi-content-ref-30745195','lexi-content-ref-28471928']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28372499','lexi-content-ref-27965228','lexi-content-ref-29472509','lexi-content-ref-30745195','lexi-content-ref-28471928'])">Ref</a></span>). Concentrations &gt;3% should be administered via central venous line only (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-16817665','lexi-content-ref-9635664']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-16817665','lexi-content-ref-9635664'])">Ref</a></span>). Consult individual institutional policies and procedures.</p>
<p style="text-indent:-2em;margin-left:4em;">3% solution: Osmolarity: 1027 mOsm/L; sodium content: 513 mEq/L.</p>
<p style="text-indent:-2em;margin-left:2em;">Higher concentrations (&gt;1%) are irritants (with vesicant-like properties at higher osmolarities); higher osmolarity is associated with a higher risk. Ensure proper needle or catheter placement prior to and during infusion; avoid extravasation.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Extravasation management:</b> If extravasation occurs, stop infusion immediately; leave cannula/needle in place temporarily but do <b>NOT</b> flush the line; gently aspirate extravasated solution, then remove needle/cannula; elevate extremity; apply dry warm compresses; initiate hyaluronidase antidote (if indicated) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33141794','lexi-content-ref-36938775']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33141794','lexi-content-ref-36938775'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Hyaluronidase:</i>
<b>Intradermal or SUBQ:</b> Inject a total of 1 mL (15 units/mL) as 5 separate 0.2 mL injections (using a tuberculin syringe) around the site of extravasation; if IV catheter remains in place, administer IV through the infiltrated catheter; may repeat in 30 to 60 minutes if no resolution (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-36938775']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-36938775'])">Ref</a></span>).</p></div>
<div class="block admp drugH1Div" id="F52613863"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Inhalation: For nebulization, not for IV administration; studies administering hypertonic saline utilized varying types of nebulizers, including jet and ultrasonic.</p>
<p style="text-indent:-2em;margin-left:2em;">Nasal: Spray into 1 nostril while gently occluding other.</p>
<p style="text-indent:-2em;margin-left:2em;">Ophthalmic: Apply to affected eye(s); avoid contact of bottle tip with eye or skin.</p>
<p style="text-indent:-2em;margin-left:2em;">Oral: Administer with full glass of water.</p>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: Central-line administration is preferred for hypertonic saline (&gt;0.9%) if available and/or if infusion is to be continued; peripheral administration may be necessary for initiation of treatment in critical patients; use of peripheral administration should be limited; intraosseous administration may be used if unable to obtain intravenous access (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22134236']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22134236'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Rate of administration:</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>0.9% isotonic solution:</b>
<i>Hypotension, shock:</i></p>
<p style="text-indent:-2em;margin-left:8em;">Neonates: Published data not available; consider slower administration to avoid IVH (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-20956231']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-20956231'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">Infants, Children, and Adolescents: Administer boluses by IV push or via rapid infusion device (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28509730']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28509730'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>3% hypertonic solution: </b></p>
<p style="text-indent:-2em;margin-left:8em;">&gt;2% solutions: Administration through a central venous line is recommended due to high osmolarity and tonicity (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-16817665']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-16817665'])">Ref</a></span>). In the absence of a central line and when urgent administration is necessary, 3% solutions may be safely administered through a peripheral venous line (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30745195','lexi-content-ref-28471928']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30745195','lexi-content-ref-28471928'])">Ref</a></span>). Consult individual institutional policies and procedures.</p>
<p style="text-indent:-2em;margin-left:10em;">
<i>Cerebral edema, diabetic ketoacidosis (DKA):</i> Bolus doses typically administered over 10 to 15 minutes. Longer infusions of 30 minutes have also been described in patients DKA (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-12749659']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-12749659'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:10em;">
<i>Increased intracranial pressure (ICP), traumatic brain injury (TBI)</i>: Bolus doses typically administered over 10 to 20 minutes (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30829890','lexi-content-ref-26673840']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30829890','lexi-content-ref-26673840'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:10em;">
<i>Symptomatic hyponatremia, severe</i>: Bolus doses typically administered over 20 minutes (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bruno.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bruno.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>23.4% hypertonic saline:</b>
<i>Increased ICP, TBI</i>: Bolus doses typically administered over 10 minutes (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30829890']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30829890'])">Ref</a></span>). Note: Concentrations &gt;3% should be administered via central venous line only (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-16817665']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-16817665'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Vesicant at higher concentrations (&gt;1%); ensure proper needle or catheter placement prior to and during infusion; avoid extravasation. If extravasation occurs, stop infusion immediately and disconnect (leave cannula/needle in place); gently aspirate extravasated solution (do <b>NOT</b> flush the line); initiate hyaluronidase antidote if indicated (see Management of Drug Extravasations for more details); remove needle/cannula; elevate extremity. Apply dry cold compresses (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24420913']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24420913'])">Ref</a></span>).</p></div>
<div class="block use drugH1Div" id="F221667"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">Inhalation: Restores moisture to pulmonary system; loosens and thins congestion caused by colds or allergies; diluent for bronchodilator solutions that require dilution before inhalation</p>
<p style="text-indent:-2em;margin-left:2em;">Intranasal: Restores moisture to nasal membranes</p>
<p style="text-indent:-2em;margin-left:2em;">Irrigation: Wound cleansing, irrigation, and flushing</p>
<p style="text-indent:-2em;margin-left:2em;">Ophthalmic: Temporary reduction of corneal edema.</p>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: Restores sodium ion in patients with restricted oral intake (especially hyponatremia states or low salt syndrome).</p>
<p style="text-indent:-2em;margin-left:4em;">Concentrated sodium chloride: Additive for parenteral fluid therapy</p>
<p style="text-indent:-2em;margin-left:4em;">Hypertonic sodium chloride: For severe hyponatremia and hypochloremia</p>
<p style="text-indent:-2em;margin-left:4em;">Hypotonic sodium chloride: Hydrating solution</p>
<p style="text-indent:-2em;margin-left:4em;">Normal saline: Restores water/sodium losses</p></div>
<div class="block off-label drugH1Div" id="F25744915"><span class="drugH1">Use: Off-Label: Adult</span><p>Cystic fibrosis; Diabetic ketoacidosis or hyperosmolar hyperglycemic state, fluid management; Hypercalcemia, volume replacement; Refractory elevated intracranial pressure; Sclerotherapy, lower-extremity venous disease; Septic shock or sepsis-induced hypoperfusion, fluid resuscitation; Subarachnoid hemorrhage; Transtentorial herniation syndrome; Traumatic brain injury with elevated intracranial pressure</p></div>
<div class="block mst drugH1Div" id="F221696"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Afrin (saline) may be confused with Afrin (oxymetazoline)</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">High alert medication:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">The Institute for Safe Medication Practices (ISMP) includes this medication (IV formulation &gt;0.9% concentration) among its list of drugs which have a heightened risk of causing significant patient harm when used in error.</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Other safety concerns:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Per The Joint Commission (TJC) recommendations, concentrated electrolyte solutions (eg, NaCl &gt;0.9%) should not be available in patient care areas.</p>
<p style="text-indent:-2em;margin-left:4em;margin-top:0em;">Inappropriate use of low sodium or sodium-free intravenous fluids (eg, D5W, hypotonic saline) in pediatric patients can lead to significant morbidity and mortality due to hyponatremia (ISMP 2009).</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13300053"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F221659"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Lithium: Sodium Chloride may increase the excretion of Lithium. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tolvaptan: Sodium Chloride may enhance the adverse/toxic effect of Tolvaptan. Specifically, Hypertonic Saline may increase the risk for too rapid of an increase in serum sodium concentrations.  Management: This interaction is specific to hypertonic saline. Avoid concurrent use of hypertonic saline with tolvaptan.<i> Risk X: Avoid combination</i></p></div>
<div class="block pri drugH1Div" id="F13888258"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Sodium and chloride requirements do not change during pregnancy (IOM 2005; NAS 2019).</p>
<p style="text-indent:0em;margin-top:2em;">Nasal saline may be used for the treatment of pregnancy rhinitis (Dykewicz 2020) and to clear nasal secretions in pregnant patients with cystic fibrosis (Edenborough 2008).</p></div>
<div class="block brc drugH1Div" id="F13888259"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Sodium and chloride are present in breast milk.</p>
<p style="text-indent:-2em;margin-left:2em;">Sodium and chloride requirements do not change during lactation (IOM 2005; NAS 2019).</p></div>
<div class="block mop drugH1Div" id="F221663"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:-2em;margin-left:2em;">Serum sodium, potassium, chloride, bicarbonate concentrations, and osmolarity; intake and output, weight. Monitor infusion site (during IV administration of hypertonic solutions).</p>
<p style="text-indent:-2em;margin-left:2em;">Diabetic ketoacidosis or hyperosmolar hyperglycemic state: Frequent monitoring (eg, every 1 to 4 hours) of serum electrolytes (eg, sodium, potassium, bicarbonate, phosphate), serum glucose, anion gap, venous pH, serum BUN, serum creatinine, serum osmolality, fluid status (eg, blood pressure, fluid intake/output, signs/symptoms of dehydration or fluid overload), anion gap, and mental status. Refer also to institutional protocols (Hirsch 2022; Kitabchi 2009).</p></div>
<div class="block rer drugH1Div" id="F221666"><span class="drugH1">Reference Range</span>
<p style="text-indent:0em;display:inline">Serum/plasma sodium concentration:</p>
<p style="text-indent:-2em;margin-left:2em;">Neonates:</p>
<p style="text-indent:-2em;margin-left:4em;">Full-term: 133 to 142 mEq/L</p>
<p style="text-indent:-2em;margin-left:4em;">Premature: 132 to 140 mEq/L</p>
<p style="text-indent:-2em;margin-left:2em;">Children ≥2 months to Adults: 135 to 145 mEq/L</p></div>
<div class="block pha drugH1Div" id="F221653"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Principal extracellular cation; functions in fluid and electrolyte balance, osmotic pressure control, and water distribution</p></div>
<div class="block phk drugH1Div" id="F221670"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Absorption: Oral: Rapid </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Distribution: Widely distributed </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Excretion: Primarily urine; also sweat, tears, saliva</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F2869407"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Apisal | Apisal stuffy nose | Clear mist | Fess | Fess little noses | Nasomist plus | Normaline | Salinex | Salinose</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Arlyt fill | Clorhyp atom | Cloruro de sodio norgreen | Larmabak | Mar v | Muro 128 | Naclor | Oftalook | Refenax salino | Relente | Respisol | Solucion Fisiologica | Solucion fisiologica de cloruro de sodio | Solucion fisiologica jayor | Solucion isotonica de cloruro de sodio | Totalatlas</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Apohealth saline | Aqafy | Chemists' Own saline | Cipla saline | Crystawash | Dimetapp infants nasal relief | Fess little noses | Flo baby saline | Metagenics nasoclear | Muro 128 | Narium natural mist | NeilMed NasaDrops | Otrivin saline | Pharmacy choice saline | Terry white chemists saline | Toppin salt | Trust for kids saline infant drops | Trust saline nasal spray | Zepclear</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Happysol | Hypersol | N sol | Ncl | Normal saline | Nosomist | Saloride | Sodiclor | Solo | Xenosol</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Chlorure de sodium | Naaprep | Physiorhine</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Chlorure de sodium | Chlorure de sodium b. braun</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Adnasal | Bem care | Blusoro jet | Clinaris | Cloreto de sodio | Cloreto de sodio baxter | Cloreto de sodio jp fisiologico | Conidrin | Conidrin baby | Deltasoro | Eflua | Fluinasal | Fluzap | Hipertonic | Maresis | Maresis ht | Maxidrate | Multisoro jet | Naridrin aqua | Naridrin bebe | Naridrin h | Naridrin jet | Narilivre | Narisoro | Narix jet | Nasalfree | Nasoclean | Nasofar | Nasofar ad | Nasojet | Nasojet 3h | Nasojet maris | Nasolac | Nasonew | Nasonew aires | Nasonew infantil | Nazosoro | Neosoro h | Novosoro h | Rinoar | Rinosoft | Rinosoft baby | Rinosoft s | Rinosoro jet xt | Rinosoro Sic | Rinospray | Salsep | Salsep jet | Salsep jet kids | Sanoclear | Sinurest | Snif | Snif sc | Snouse | So-Soro Infantil | Solucao de cloreto de sodio b.braun | Solucao fisiologica | Solucao fisiologica a 0,9% | Solucao fisiologica de cloreto de sodio | Solucao fisiologica de cloreto de sodio equiplex | Solucion Fisiologica | Solusam | Sonarin infantil | Soridrat | Sorine | Sorine h | Sorisma e | Soro fisiologico | Sorofar | Sorofar H | Soroliv hipertonico | Soroneo | Triane soro fisiologico</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Hydrabak | NaCl | NaCl b.braun | NaCl Bioren | NaCl Fresenius | Nacl sintetica | Otrivin natural | Physiologic gifrer | Siccoral</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Axaline ns | Chlorure de sodium | Sodium chlorure nirma | Steriline | Steriline plus</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Fisiolimp | Larmabak | Mokit off | Mokit off kids | Nasakid | Nasalub max | Nasamist | Nasitral</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Ai na duo | Sodium chloride physiological</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Afrisal | Allerzitina | Bio nasal | Cloruro de sodio | Efrimel nasal | Fisioline | Fluimucil Aqua | Frekaflex | Humenas | Humenas gl | Na trol | Nasaler | Nasalub adultos | Nasivin aqua | Natrum mur | Physiocean | Rhifisol | Sinuphis | Sodio cloruro | Solucion cs pisa | Solucion fisiologica de cloruro de sodio | Solucion salina | Solucion salina normal | Suero fisiologico | Suero fisiologico nasalin</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Ardeaelytosol conc. natriumchlorid | Ardeaelytosol f 1/1 | Fyziologicky roztok viaflo</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Abtei meersalz | Biochemie pfluger nr 8 | Broncholind nasen | Coldamaris | Hysan salinspray | Kochsalz | NaCl b.braun | Nasendusche | Omni sorb | Schwedentabletten | Siccoral | Sm</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Cloruro de sodio | Clorusod | Hiperton | Hypersol | Sanalimp | Solucion cs pisa</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Afrisal | Bioglo tear | Cloruro de sodio | Cloruro de sodio sanderson | Fisiol ub | Fisionasal | Nasoclean | Nasoxy | Retaine NaCl | Suero fisiologico</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Coldamaris | Edenorm | Hydrabak | Miwana | Muro 128 | Sodium chloride kabi</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Salinex | Salinol</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Bucalsone | Hidrathea | Meinvenil fisiologico | Salina fisiologica grifols</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Abnal | Normal saline | Ns</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Natriumklorid abcur | Otrimer</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Larmabak | Multilarm | Unilarm</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Calpol Saline Nasal Drops | Calpol Saline Nasal Spray | Easyflex n iso nacl | Irriclens | Mucoclear | Nasosal | Optiflo s | Pf drops sodium chloride | Sodiclor | Sterile mandanol | Sterowash | Syrisal | Tixylix</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Sodium chlorid/baxter | Sodium chloride demo | Sodium chloride/bradex</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Larmabak</span>;</li>
<li>
<span class="countryCode">(HN)</span> <span class="country">Honduras</span><span class="countrySeparator">: </span><span class="drugName">Nostrila</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Natrii chloridi infundibile | Natrijev klorid | Natrijev klorid viaflo</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Salsol</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Iliadin moist | Sanbreth</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Sodium chloride braun | Stericlens | Syrisal | Tixylix</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Tipotaf</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Acolate saline | Acusalt | Addna | Clarivion | Clearnoz ns | Cliarway | Easnoze | Ecoflac plus ns | Hafnor | Hitsol | I rinse | Isol | Karvol clear | Lcz ns | Maxtra s | Moistwin | Musing | Nasalt | Naseon | Nasivion s | Nasoclear | Nasoclear plus | Nasokid | Nasomist | Nazalin s | Nazodrop | Nazone | Nazosis | Nesobest s | Noseon | Nozeclear | Nozuka nasal spray | Nusodium | Osmogel | Osolin | Rhinoset s | Salin | Salinex | Saltnase | Sane ns | Sinomet s | Socl | Sodeem | Soline | Solspre | Solvin | Vilco nasal drops s | Vitrinal | Zoamet s</span>;</li>
<li>
<span class="countryCode">(IQ)</span> <span class="country">Iraq</span><span class="countrySeparator">: </span><span class="drugName">Baby nose</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Edenorm | Sodio cloruro baxter s.p.a. | Sodio cloruro Gambro Dasco | Sodio cloruro panpharma</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Apisal | Drossa Nose | Edenorm | Hynasal | Nasosal | Nazex</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Abnal | Nasosal | Normal saline | Novorin | Ns | Rinz normal saline | Saline</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Binex isotonic sodium chloride | Cleancle | Conafresh | Daihan isotonic sodium chloride | Daihan sodium chloride | Daihan sodium chloride 40 | Encle | Fess natural | Huons sodium chloride | Hypertonicity ophthalmic | Inno.n 0.45% sodium chloride | Inno.n 0.9% sodium chloride | Inno.n 0.9% sodium chloride irrigation | Jw 0.45% sodium chloride | Jw ns | Klenzo | Metarivin nasal wash | Mg normal saline | Muro 128 | Nasaline plus | Otrisal | Otrivin baby natural | Samjin normal saline | Sodium chlorid | Uk sodium chloride</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Antiedema | Fess eucalyptus | Fess little noses | Fess original | Nasosal | Nisita</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Physiosol | Salinose | Serum physiologique</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Edenorm</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Coldamaris | Edenorm | Hydrabak | Natrii chloridum | Normgel | Tetrisoft e</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Larmabak | Ocusalin | Rhina care</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Biogalenic ele | Brisamar | Clorurosodica alpha | Ecf ns | Hiperton | Misalati | Nasalub adultos | Salt claire | Sodiamsa | Solucion cs c 17.7% pisa | Solucion cs pisa | Solucion isotonica de cloruro de sodio al 0.9% pisa | Solucion isotonica de cloruro de sodio cryopharma | Ssb pisa</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Cleaq | Infusol hs | Infusol S3</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Bioflex sodium chloride | Normal saline | Salacyn | Unisal | Vitadium</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Natriumchloride</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Muro 128 | Natriumklor naf | Natriumklorid abboxia | Natriumklorid abcur | Natriumklorid apl | Sodium chloride akorn</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Apohealth saline | Medco sinus clear | Muro 128 | Pharmacy health saline | Schuessler tissue salts fluid balance nat mur | Trust saline nasal spray</span>;</li>
<li>
<span class="countryCode">(OM)</span> <span class="country">Oman</span><span class="countrySeparator">: </span><span class="drugName">Apisal</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Cloruro de sodio | Rhino bb | Rhino clo | Rinokid</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Euro Med Sodium Chloride | Hyperton opta | Nasalden | Nasoclear | Salinase | Sydenase</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Celine | Gee sol ns | Immuasol ns | Macsol ns | Medisol ns | Nadosaline | Normal saline | Norsaline p | Nsline | Revasol ns | Safesol ns | Salub | Searle ns | Unisol ns | Visoline | Zeesol ns</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Natrium chloratum baxter | Nebu dose hipertonic | Ocusalin</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Atrapro dermal | Nasamist | Neilmed pediamist</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Cloreto de sodio | Salina fisiologica grifols</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Baby rhinol | Bonair | Cloruro de sodio 3 molar catedral | Cloruro de sodio 3 molar dutriec | Cloruro de sodio 3 molar lasca | Cloruro de sodio bergamo | Cloruro de sodio prosalud | Cloruro de sodio sanderson | Hypersol | Nasoplus | Nicorin | Parsol | Rhino mar | Silimar | Solucion fisiologica de cloruro de sodio b braun | Solucion fisiologica de cloruro de sodio baxter | Solucion fisiologica de cloruro de sodio demotek | Solucion fisiologica de cloruro de sodio roux ocefa | Solucion fisiologica diproan | Solucion fisiologica isotonica imeg | Suero fisiologico | Suero fisiologico icu vita | Xylisol cassara</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Apisal | Apisal Jet Dead Sea Adult &amp; Children | Apisal Jet Dead Sea Baby | Nisita | Norsalin | Rinomist Spray | Sterimar Congestion Relief | Steripod UD</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Larmabak</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Aqua rinosol | Aquamaster | Natrium chloridum | Nazol aqua | Physiodose | Rizosin | Salin | Sodium chlorid</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Apisal | Drossa Nose | Edenorm | Nasosal | Normaline | Salinex | Salinose hypertonic</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Addex-natriumklorid | Natriumklorid abboxia | Natriumklorid abcur | Natriumklorid braun</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Hypergel | Larmabak | Naspira | Normlgel | Otrivin saline | Rinz normal saline</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Fizioloska raztopina za nos</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Chlorid sodny 0,9 % Imuna envibag | Infusio natrii chlorati isotonica imuna</span>;</li>
<li>
<span class="countryCode">(SL)</span> <span class="country">Sierra Leone</span><span class="countrySeparator">: </span><span class="drugName">Ns</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Hashi baby drop gentle formula | Soride | Virx nasal spray</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Chlorure de sodium | Chlorure sodium | Nasoclean | Rhina care | Tonimer Baby</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Hipertonik sodyum klorur | Izotonik sodyum klorur bfs | Lafleks izotonik sodyum klorur | Larmabak | Neofleks izotonik sodyum klorur sudaki solusyonu | Polifleks %0,9 izotonik sodyum klorur | Pro fleks izotonik sodyum klorur | Sodyum klorur | Turkfleks izotonik sodyum klorur</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Aquamax | Natrium chloratum | No sol | Nosalen | Solutio Natrii chloridi</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Abnal | Ns</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Beltears | Cloruro de sodio | Narixol | Nasal | Nasitral | Saline | Saline hipertonico | Snif | Snif sc | Xylisol | Xylisol cassara</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Fisiolin | Larmabak | Salafrin</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Natri clorid</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Aquamist | Autoststeril sodium chloride | Bennetts Saline Nose Spray | Euro Med Sodium Chloride | Flamirins | Iliadin saline nose drops | Just saline | Kleer Naze | Kuraflo | Linctagon | Linctomed | Sabax pour saline | Saline spray</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Abnal | Sabax sodium chloride</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Sodium chloride b.braun | Sodium chloride fresenius | Sodium chloride iv</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-28704229">
<a name="28704229"></a>Achinger SG, Ayus JC. Treatment of hyponatremic encephalopathy in the critically ill. <i>Crit Care Med.</i> 2017;45(10):1762-1771. doi:10.1097/CCM.0000000000002595<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28704229/pubmed" id="28704229" target="_blank">28704229</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Addipak.1">
<a name="Addipak.1"></a>Addipak (sodium chloride) [prescribing information]. Morrisville, NC: Teleflex Medical; received November 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12847347">
<a name="12847347"></a>Adelson PD, Bratton SL, Carney NA, et al. Guidelines for the Acute Medical Management of Severe Traumatic Brain Injury in Infants, Children, and Adolescents. Chapter 11. Use of Hyperosmolar Therapy in the Management of Severe Pediatric Traumatic Brain Injury. <i>Pediatr Crit Care Med</i>. 2003;4(3)(suppl):40-44.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/12847347/pubmed" id="12847347" target="_blank">12847347</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10816188">
<a name="10816188"></a>Adrogué HJ, Madias NE. Hypernatremia. <i>N Engl J Med.</i> 2000;342(20):1493-1499. doi:10.1056/NEJM200005183422006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/10816188/pubmed" id="10816188" target="_blank">10816188</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22626822">
<a name="22626822"></a>Adrogué HJ, Madias NE. The Challenge of Hyponatremia. <i>J Am Soc Nephrol</i>. 2012;23(7):1140-1148.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/22626822/pubmed" id="22626822" target="_blank">22626822</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11882555">
<a name="11882555"></a>Al-Dahhan J, Jannoun L, Haycock GB. Effect of Salt Supplementation of Newborn Premature Infants on Neurodevelopmental Outcome at 10-13 Years of Age. <i>Arch Dis Child Fetal Neonatal Ed</i>. 2002;86(2):F120-F123.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/11882555/pubmed" id="11882555" target="_blank">11882555</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19910550">
<a name="19910550"></a>Al-Rawi PG, Tseng MY, Richards HK, et al. Hypertonic saline in patients with poor-grade subarachnoid hemorrhage improves cerebral blood flow, brain tissue oxygen, and pH. <i>Stroke</i>. 2010;41(1):122-128. doi:10.1161/STROKEAHA.109.560698<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/19910550/pubmed" id="19910550" target="_blank">19910550</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20435858">
<a name="20435858"></a>Amin R, Subbarao P, Jabar A, et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. <i>Thorax</i>. 2010;65(5):379-383.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/20435858/pubmed" id="20435858" target="_blank">20435858</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18203044">
<a name="18203044"></a>Badjatia N, Carney N, Crocco TJ, et al. Guideline for Prehospital Management of Traumatic Brain Injury 2nd Edition. <i>Prehosp Emerg Care</i>. 2008;12(suppl 1):1-52.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/18203044/pubmed" id="18203044" target="_blank">18203044</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-4708280">
<a name="4708280"></a>Barer J, Hill LL, Hill RM, et al. Fatal Poisoning From Salt Used as an Emetic. <i>Am J Dis Child</i>. 1973;125(6):889-890.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/4708280/pubmed" id="4708280" target="_blank">4708280</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32044213">
<a name="32044213"></a>Bennett BL, Hew-Butler T, Rosner MH, Myers T, Lipman GS. Wilderness Medical Society clinical practice guidelines for the management of exercise-associated hyponatremia: 2019 update. <i>Wilderness Environ Med</i>. 2020;31(1):50-62. doi:10.1016/j.wem.2019.11.003<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/32044213/pubmed" id="32044213" target="_blank">32044213</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15075723">
<a name="15075723"></a>Bhardwaj A, Ulatowski JA. Hypertonic Saline Solutions in Brain Injury. <i>Curr Opin Crit Care</i>. 2004;10(2):126-131.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/15075723/pubmed" id="15075723" target="_blank">15075723</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19914445">
<a name="19914445"></a>Borowitz D, Robinson KA, Rosenfeld M, et al; Cystic Fibrosis Foundation. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. <i>J Pediatr</i>. 2009;155(6)(suppl):S73-S93. doi:10.1016/j.jpeds.2009.09.001<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/19914445/pubmed" id="19914445" target="_blank">19914445</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17511534">
<a name="17511534"></a>Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the Management of Severe Traumatic Brain Injury. <i>J Neurotrauma</i>. 2007;24(suppl 1):1-106.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/17511534/pubmed" id="17511534" target="_blank">17511534</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-BTF.1">
<a name="BTF.1"></a>Brain Trauma Foundation. Guidelines for the Field Management of Combat-Related Head Trauma. 2005. http://www.braintrauma.org
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23283268">
<a name="23283268"></a>Brenkert TE, Estrada CM, McMorrow SP, Abramo TJ. Intravenous hypertonic saline use in the pediatric emergency department. <i>Pediatr Emerg Care</i>. 2013;29(1):71-73.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/23283268/pubmed" id="23283268" target="_blank">23283268</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19325359">
<a name="19325359"></a>Brierley J, Carcillo JA, Choong K, et al. Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock: 2007 Update from the American College of Critical Care Medicine. <i>Crit Care Med</i>. 2009;37(2):666-688.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/19325359/pubmed" id="19325359" target="_blank">19325359</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bruno.1">
<a name="Bruno.1"></a>Bruno J, Canada T, Canada N, Tucker A, Ybarra J, eds. <i>ASPEN Fluids, Electrolytes, and Acid-Base Disorders Handbook</i>. 2nd ed. Silver Spring: MD: American Society of Parenteral and Enteral Nutrition, 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10069912">
<a name="10069912"></a>Bukhari RH, Lohr JM, Paget DS, Hearn AT, Cranley RD. Evaluation of lidocaine as an analgesic when added to hypertonic saline for sclerotherapy.<i> J Vasc Surg.</i> 1999;29(3):479-483. doi:10.1016/s0741-5214(99)70276-4<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/10069912/pubmed" id="10069912" target="_blank">10069912</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26825644">
<a name="26825644"></a>Burgess S, Abu-Laban RB, Slavik RS, Vu EN, Zed PJ. A systematic review of randomized controlled trials comparing hypertonic sodium solutions and mannitol for traumatic brain injury: implications for emergency department management. <i>Ann Pharmacother</i>. 2016;50(4):291-300.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/26825644/pubmed" id="26825644" target="_blank">26825644</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28913634">
<a name="28913634"></a>Cadena R, Shoykhet M, Ratcliff JJ. Emergency neurological life support: intracranial hypertension and herniation. <i>Neurocrit Care</i>. 2017;27(suppl 1):S82-S88. doi:10.1007/s12028-017-0454-z<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28913634/pubmed" id="28913634" target="_blank">28913634</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27654000">
<a name="27654000"></a>Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury. <i>Neurosurgery.</i> 2017;80(1):6-15. doi:10.1227/NEU.0000000000001432<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/27654000/pubmed" id="27654000" target="_blank">27654000</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29506920">
<a name="29506920"></a>Castellani C, Duff AJA, Bell SC, et al. ECFS best practice guidelines: the 2018 revision. <i>J Cyst Fibros</i>. 2018;17(2):153-178. doi:10.1016/j.jcf.2018.02.006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/29506920/pubmed" id="29506920" target="_blank">29506920</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9685464">
<a name="9685464"></a>Ceneviva G, Paschall JA, Maffei F, Carcillo JA. Hemodynamic support in fluid-refractory pediatric septic shock. <i>Pediatrics</i>. 1998;102(2):e19.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/9685464/pubmed" id="9685464" target="_blank">9685464</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26844975">
<a name="26844975"></a>Chang R, Holcomb JB. Choice of fluid therapy in the initial management of sepsis, severe sepsis, and septic shock. <i>Shock</i>. 2016;46(1):17-26. doi:10.1097/SHK.0000000000000577<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/26844975/pubmed" id="26844975" target="_blank">26844975</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22556195">
<a name="22556195"></a>Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al; American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. <i>Stroke</i>. 2012;43(6):1711-1737.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/22556195/pubmed" id="22556195" target="_blank">22556195</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Corkins.1">
<a name="Corkins.1"></a>Corkins MR, Balint J, Bobo E, et al, eds. <i>The A.S.P.E.N Pediatric Nutrition Support Core Curriculum</i>. 2nd ed. Silver Spring: MD: American Society of Parenteral and Enteral Nutrition, 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28509730">
<a name="28509730"></a>Davis AL, Carcillo JA, Aneja RK, et al. American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock [published correction appears in <i>Crit Care Med</i>. 2017;45(9):e993]. <i>Crit Care Med</i>. 2017;45(6):1061-1093.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28509730/pubmed" id="28509730" target="_blank">28509730</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17966153">
<a name="17966153"></a>Dietzek CL. Sclerotherapy: introduction to solutions and techniques.<i> Perspect Vasc Surg Endovasc Ther.</i> 2007;19(3):317-324. doi:10.1177/1531003507305884<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/17966153/pubmed" id="17966153" target="_blank">17966153</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21773873">
<a name="21773873"></a>Diringer MN, Bleck TP, Hemphill JC 3rd, et al; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. <i>Neurocrit Care</i>. 2011;15(2):211-240.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/21773873/pubmed" id="21773873" target="_blank">21773873</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23353941">
<a name="23353941"></a>Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. <i>Crit Care Med</i>. 2013;41(2):580-637.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/23353941/pubmed" id="23353941" target="_blank">23353941</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18828160">
<a name="18828160"></a>Dellon EP, Donaldson SH, Johnson R, et al. Safety and Tolerability of Inhaled Hypertonic Saline in Young Children With Cystic Fibrosis. <i>Pediatr Pulmonol</i>. 2008;43(11):1100-1106.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/18828160/pubmed" id="18828160" target="_blank">18828160</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28372499">
<a name="28372499"></a>Dillon RC, Merchan C, Altshuler D, Papadopoulos J. Incidence of adverse events during peripheral administration of sodium chloride 3. <i>J Intensive Care Med</i>. 2018;33(1):48-53. doi:10.1177/0885066617702590<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28372499/pubmed" id="28372499" target="_blank">28372499</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32707227">
<a name="32707227"></a>Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. <i>J Allergy Clin Immunol</i>. 2020;146(4):721-767. doi:10.1016/j.jaci.2020.07.007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/32707227/pubmed" id="32707227" target="_blank">32707227</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18024241">
<a name="18024241"></a>Edenborough FP, Borgo G, Knoop C, et al; European Cystic Fibrosis Society. Guidelines for the management of pregnancy in women with cystic fibrosis.<i> J Cyst Fibros</i>. 2008;7(suppl 1):S2-S32. doi:10.1016/j.jcf.2007.10.001<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/18024241/pubmed" id="18024241" target="_blank">18024241</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28146603">
<a name="28146603"></a>Elkins M, Dentice R. Timing of hypertonic saline inhalation for cystic fibrosis. <i>Cochrane Database Syst Rev</i>. 2016;12:CD008816. doi:10.1002/14651858.CD008816.pub3<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28146603/pubmed" id="28146603" target="_blank">28146603</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16421364">
<a name="16421364"></a>Elkins MR, Robinson M, Rose BR, et al; National Hypertonic Saline in Cystic Fibrosis (NHSCF) study group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. <i>N Engl J Med</i>. 2006;354(3):229-240. doi:10.1056/NEJMoa043900<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/16421364/pubmed" id="16421364" target="_blank">16421364</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34605781">
<a name="34605781"></a>Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. <i>Crit Care Med.</i> 2021;49(11):e1063-e1143. doi:10.1097/CCM.0000000000005337<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/34605781/pubmed" id="34605781" target="_blank">34605781</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25389139">
<a name="25389139"></a>Everard ML, Hind D, Ugonna K, et al. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. <i>Thorax</i>. 2014;69(12):1105-1112.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/25389139/pubmed" id="25389139" target="_blank">25389139</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30328363">
<a name="30328363"></a>Farrokh S, Cho SM, Lefebvre AT, Zink EK, Schiavi A, Puttgen HA. Use of intraosseous hypertonic saline in critically ill patients. <i>J Vasc Access</i>. 2019;20(4):427-432. doi:10.1177/1129729818805958<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/30328363/pubmed" id="30328363" target="_blank">30328363</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15163774">
<a name="15163774"></a>Finfer S, Bellomo R, Boyce N, et al. A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit. SAFE Study Investigators. <i>N Engl J Med</i>. 2004;350(22):2247-2256. doi:10.1056/NEJMoa040232<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/15163774/pubmed" id="15163774" target="_blank">15163774</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35041780">
<a name="35041780"></a>Finfer S, Micallef S, Hammond N, et al. Balanced multielectrolyte solution versus saline in critically ill adults. <i>N Engl J Med</i>. 2022;386(9):815-826. doi:10.1056/NEJMoa2114464<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/35041780/pubmed" id="35041780" target="_blank">35041780</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15815431">
<a name="15815431"></a>Fisher B, Thomas D, Peterson B. Hypertonic Saline Lowers Raised Intracranial Pressure in Children After Head Trauma. <i>J Neurosurg Anesthesiol</i>. 1992;4(1):4-10.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/15815431/pubmed" id="15815431" target="_blank">15815431</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26334188">
<a name="26334188"></a>Flores P, Mendes AL, Neto AS. A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants. <i>Pediatr Pulmonol</i>. 2016;51(4):418-425<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/26334188/pubmed" id="26334188" target="_blank">26334188</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18363531">
<a name="18363531"></a>Forsyth LL, Liu-DeRyke X, Parker D, et al. Role of Hypertonic Saline for the Management of Intracranial Hypertension After Stroke and Traumatic Brain Injury. <i>Pharmacotherapy</i>. 2008;28(4):469-484.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/18363531/pubmed" id="18363531" target="_blank">18363531</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21536172">
<a name="21536172"></a>Gloviczki P, Comerota AJ, Dalsing MC, et al; Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. <i>J Vasc Surg.</i> 2011;53(5 Suppl):2S-48S. doi:10.1016/j.jvs.2011.01.079<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/21536172/pubmed" id="21536172" target="_blank">21536172</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27170690">
<a name="27170690"></a>Goldner W. Cancer-related hypercalcemia. <i>J Oncol Pract</i>. 2016;12(5):426-432. doi:10.1200/JOP.2016.011155<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/27170690/pubmed" id="27170690" target="_blank">27170690</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25061324">
<a name="25061324"></a>Gosmanov AR, Gosmanova EO, Dillard-Cannon E. Management of adult diabetic ketoacidosis. <i>Diabetes Metab Syndr Obes</i>. 2014;7:255-264. doi:10.2147/DMSO.S50516<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/25061324/pubmed" id="25061324" target="_blank">25061324</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7095681">
<a name="7095681"></a>Gresham GS, Mashru MK. Fatal Poisoning With Sodium Chloride. <i>Forensic Sci Int</i>. 1982;20:87-88.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/7095681/pubmed" id="7095681" target="_blank">7095681</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17667395">
<a name="17667395"></a>Hadaway L. Infiltration and extravasation. <i>Am J Nurs</i>. 2007;107(8):64-72.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/17667395/pubmed" id="17667395" target="_blank">17667395</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31364382">
<a name="31364382"></a>Hammond DA, Lam SW, Rech MA, et al. Balanced crystalloids versus saline in critically ill adults: a systematic review and meta-analysis. <i>Ann Pharmacother.</i> 2020;54(1):5-13. doi:10.1177/1060028019866420<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/31364382/pubmed" id="31364382" target="_blank">31364382</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hirsch.1">
<a name="Hirsch.1"></a>Hirsch IB, Emmett M. Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: treatment. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="https://www.uptodate.com" target="_blank">https://www.uptodate.com</a>. Accessed April 20, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16720165">
<a name="16720165"></a>Huang SJ, Chang L, Han YY, et al. Efficacy and Safety of Hypertonic Saline Solutions in the Treatment of Severe Head Injury. <i>Surg Neurol</i>. 2006;65(6):539-546.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/16720165/pubmed" id="16720165" target="_blank">16720165</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-HyperSal.1">
<a name="HyperSal.1"></a>HyperSal (sodium chloride) [prescribing information]. Starnberg, Germany: PARI; received June 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-IOM.1">
<a name="IOM.1"></a>Institute of Medicine (IOM). <i>Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate</i>. The National Academies Press; 2005. https://doi.org/10.17226/10925
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30087153">
<a name="30087153"></a>Inwald DP, Canter R, Woolfall K, et al. Restricted fluid bolus volume in early septic shock: results of the Fluids in Shock pilot trial. <i>Arch Dis Child</i>. 2019;104(5):426-431. doi:10.1136/archdischild-2018-314924<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/30087153/pubmed" id="30087153" target="_blank">30087153</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30588284">
<a name="30588284"></a>Islam T, Sherani K, Surani S, Vakil A. Guidelines and controversies in the management of diabetic ketoacidosis - a mini-review. <i>World J Diabetes</i>. 2018;9(12):226-229. doi:10.4239/wjd.v9.i12.226<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/30588284/pubmed" id="30588284" target="_blank">30588284</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-National.1">
<a name="National.1"></a>Joint Commission on Accreditation of Healthcare Organizations. 2005 National Patient Safety Goals. http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/05_npsgs.htm
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27965228">
<a name="27965228"></a>Jones GM, Bode L, Riha H, Erdman MJ. Safety of continuous peripheral infusion of 3% sodium chloride solution in neurocritical care patients.<i> Am J Crit Care</i>. 2016;26(1):37-42.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/27965228/pubmed" id="27965228" target="_blank">27965228</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12749659">
<a name="12749659"></a>Kamat P, Vats A, Gross M, et al. Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis.<i> Pediatr Crit Care Med</i>. 2003;4(2):239-242.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/12749659/pubmed" id="12749659" target="_blank">12749659</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24172851">
<a name="24172851"></a>Kamin W, Erdnüss F, Krämer I. Inhalation solutions--which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers--update 2013. <i>J Cyst Fibros</i>. 2014;13(3):243-250. doi:10.1016/j.jcf.2013.09.006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/24172851/pubmed" id="24172851" target="_blank">24172851</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20956231">
<a name="20956231"></a>Kattwinkel J, Perlman JM, Aziz K, et al. Part 15: Neonatal Resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. <i>Circulation</i>. 2010;122(18)(suppl 3):909-919.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/20956231/pubmed" id="20956231" target="_blank">20956231</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19667879">
<a name="19667879"></a>Kerwin AJ, Schinco MA, Tepas JJ 3rd, Renfro WH, Vitarbo EA, Muehlberger M. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. <i>J Trauma.</i> 2009;67(2):277-282. doi:10.1097/TA.0b013e3181acc726<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/19667879/pubmed" id="19667879" target="_blank">19667879</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10809296">
<a name="10809296"></a>Khanna S, Davis D, Peterson B, et al. Use of Hypertonic Saline in the Treatment of Severe Refractory Posttraumatic Intracranial Hypertension in Pediatric Traumatic Brain Injury. <i>Crit Care Med</i>. 2000;28(4):1144-1151.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/10809296/pubmed" id="10809296" target="_blank">10809296</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21568230">
<a name="21568230"></a>Khoury N, Carmichael KA. Evaluation and therapy of hypercalcemia. <i>Mo Med</i>. 2011;108(2):99-103.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/21568230/pubmed" id="21568230" target="_blank">21568230</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19564476">
<a name="19564476"></a>Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. <i>Diabetes Care</i>. 2009;32(7):1335-1343. doi:10.2337/dc09-9032<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/19564476/pubmed" id="19564476" target="_blank">19564476</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22217782">
<a name="22217782"></a>Kochanek PM, Carney N, Adelson PD, et al. Guidelines for the Acute Medical Management of Severe Traumatic Brain Injury in Infants, Children, and Adolescents -- Second Edition. <i>Pediatr Crit Care Med</i>. 2012;13(suppl 1):1-82.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/22217782/pubmed" id="22217782" target="_blank">22217782</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30829890">
<a name="30829890"></a>Kochanek PM, Tasker RC, Carney N, et al. Guidelines for the management of pediatric severe traumatic brain injury, third edition: update of the Brain Trauma Foundation guidelines [published correction appears in <i>Pediatr Crit Care Med</i>. 2019;20(4):404]. <i>Pediatr Crit Care Med</i>. 2019;20(3S)(suppl 1):S1-S82.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/30829890/pubmed" id="30829890" target="_blank">30829890</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18272864">
<a name="18272864"></a>Koenig MA, Bryan M, Lewin JL 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. <i>Neurology.</i> 2008;70(13):1023-1029. doi:10.1212/01.wnl.0000304042.05557.60<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/18272864/pubmed" id="18272864" target="_blank">18272864</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16085929">
<a name="16085929"></a>Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. <i>Am J Health-Syst Pharm.</i> 2005;62(16):1663-1682.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/16085929/pubmed" id="16085929" target="_blank">16085929</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17719935">
<a name="17719935"></a>Kuzik BA, Al-Qadhi SA, Kent S, et al. Nebulized Hypertonic Saline in the Treatment of Viral Bronchiolitis in Infants. <i>J Pediatr</i>. 2007;151(3):266-270, 270.e1.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/17719935/pubmed" id="17719935" target="_blank">17719935</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27009033">
<a name="27009033"></a>Lahiri T, Hempstead SE, Brady C, et al. Clinical practice guidelines from the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis. <i>Pediatrics</i>. 2016;137(4):e20151784.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/27009033/pubmed" id="27009033" target="_blank">27009033</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29767636">
<a name="29767636"></a>Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. <i>Crit Care Med</i>. 2018;46(6):997-1000. doi:10.1097/CCM.0000000000003119<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/29767636/pubmed" id="29767636" target="_blank">29767636</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24026522">
<a name="24026522"></a>Lewandowski-Belfer JJ, Patel AV, Darracott RM, Jackson DA, Nordeen JD, Freeman WD. Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension. <i>Neurocrit Care</i>. 2014;20(3):436-442. doi:10.1007/s12028-013-9907-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/24026522/pubmed" id="24026522" target="_blank">24026522</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-LittleRemedies.1">
<a name="LittleRemedies.1"></a>Little Remedies for Noses Saline Spray + Drops (sodium chloride) [prescribing information]. Lynchburg, VA: Prestige Consumer Healthcare Inc; no date.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22470080">
<a name="22470080"></a>Lobo DN. Intravenous 0.9% saline and general surgical patients: a problem, not a solution. <i>Ann Surg</i>. 2012;255(5):830-832. doi:10.1097/SLA.0b013e318250766c<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/22470080/pubmed" id="22470080" target="_blank">22470080</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22134236">
<a name="22134236"></a>Luu JL, Wendtland CL, Gross MF, et al. Three-Percent Saline Administration During Pediatric Critical Care Transport. <i>Pediatr Emerg Care</i>. 2011;27(12):1113-1117.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/22134236/pubmed" id="22134236" target="_blank">22134236</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28215427">
<a name="28215427"></a>Maguigan KL, Dennis BM, Hamblin SE, Guillamondegui OD. Method of hypertonic saline administration: effects on osmolality in traumatic brain injury patients. <i>J Clin Neurosci</i>. 2017;39:147-150. doi:10.1016/j.jocn.2017.01.025<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28215427/pubmed" id="28215427" target="_blank">28215427</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24130250">
<a name="24130250"></a>Maier JD, Levine SN. Hypercalcemia in the intensive care unit: a review of pathophysiology, diagnosis, and modern therapy. <i>J Intensive Care Med</i>. 2015;30(5):235-252. doi:10.1177/0885066613507530<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/24130250/pubmed" id="24130250" target="_blank">24130250</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19570736">
<a name="19570736"></a>Makras P, Papapoulos SE. Medical treatment of hypercalcaemia. <i>Hormones (Athens)</i>. 2009;8(2):83-95. doi:10.14310/horm.2002.1225<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/19570736/pubmed" id="19570736" target="_blank">19570736</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21942597">
<a name="21942597"></a>Marcialis MA, Dessi A, Pintus MC, et al. Neonatal Hyponatremia: Differential Diagnosis and Treatment. <i>J Matern Fetal Neonatal Med</i>. 2011;24(suppl 1):75-79.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/21942597/pubmed" id="21942597" target="_blank">21942597</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10469077">
<a name="10469077"></a>McCoy S, Evans A, Spurrier N. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline. <i>Dermatol Surg.</i> 1999;25(5):381-385; discussion 385-386. doi:10.1046/j.1524-4725.1999.08263.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/10469077/pubmed" id="10469077" target="_blank">10469077</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8503665">
<a name="8503665"></a>Meadow R. Nonaccidental Salt Poisoning. <i>Arch Dis Child</i>. 1993;68(4):448-452.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/8503665/pubmed" id="8503665" target="_blank">8503665</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29472509">
<a name="29472509"></a>Meng L, Nguyen CM, Patel S, Mlynash M, Caulfield AF. Association between continuous peripheral i.v. infusion of 3% sodium chloride injection and phlebitis in adults. <i>Am J Health Syst Pharm</i>. 2018;75(5):284-291. doi:10.2146/ajhp161028<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/29472509/pubmed" id="29472509" target="_blank">29472509</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30745195">
<a name="30745195"></a>Mesghali E, Fitter S, Bahjri K, Moussavi K. Safety of peripheral line administration of 3% hypertonic saline and Mannitol in the emergency department. <i>J Emerg Med</i>. 2019;56(4):431-436. doi:10.1016/j.jemermed.2018.12.046<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/30745195/pubmed" id="30745195" target="_blank">30745195</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23055905">
<a name="23055905"></a>Meyers R. Pediatric Fluid and Electrolyte Therapy. <i>J Pediatr Pharmacol Ther</i>. 2009;14:204-211<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/23055905/pubmed" id="23055905" target="_blank">23055905</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15568296">
<a name="15568296"></a>Mirtallo J, Canada T, Johnson D, et al; Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition [published correction appears in <i>JPEN J Parenter Enteral Nutr</i>. 2006;30(2):177]. <i>JPEN J Parenter Enteral Nutr.</i> 2004;28(6):S39-S70.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/15568296/pubmed" id="15568296" target="_blank">15568296</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2255221">
<a name="2255221"></a>Moder KG, Hurley DL. Fatal Hypernatremia From Exogenous Salt Intake: Report of a Case and Review of the Literature. <i>Mayo Clin Proc</i>. 1990;65(12):1587-1594.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/2255221/pubmed" id="2255221" target="_blank">2255221</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23540878">
<a name="23540878"></a>Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al; Pulmonary Clinical Practice Guidelines Committee. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. <i>Am J Respir Crit Care Med</i>. 2013;187(7):680-689.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/23540878/pubmed" id="23540878" target="_blank">23540878</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29327810">
<a name="29327810"></a>Morikawa Y, Miura M, Furuhata MY, et al. Nebulized hypertonic saline in infants hospitalized with moderately severe bronchiolitis due to RSV infection: A multicenter randomized controlled trial. <i>Pediatr Pulmonol</i>. 2018;53(3):358-365.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/29327810/pubmed" id="29327810" target="_blank">29327810</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16817665">
<a name="16817665"></a>Mortimer DS, Jancik J. Administering hypertonic saline to patients with severe traumatic brain injury. <i>J Neurosci Nurs</i>. 2006;38(3):142-146.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/16817665/pubmed" id="16817665" target="_blank">16817665</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10674757">
<a name="10674757"></a>Munar F, Ferrer AM, de Nadal M, et al. Cerebral Hemodynamic Effects of 7.2% Hypertonic Saline in Patients With Head Injury and Raised Intracranial Pressure. <i>J Neurotrauma</i>. 2000;17(1):41-51.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/10674757/pubmed" id="10674757" target="_blank">10674757</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Muro 128 (sodium chloride) 2% solution [prescribing information]. Bridgewater, NJ: Bausch &amp; Lomb; May 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Muro.1">
<a name="Muro.1"></a>Muro 128 (sodium chloride) 5% solution [prescribing information]. Bridgewater, NJ: Bausch &amp; Lomb; May 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Muro.2">
<a name="Muro.2"></a>Muro 128 (sodium chloride) ophthalmic ointment [prescribing information]. Bridgewater, NJ: Bausch &amp; Lomb; April 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NAS.1">
<a name="NAS.1"></a>National Academies of Sciences (NAS), Engineering, and Medicine. Dietary Reference Intakes for Sodium and Potassium. The National Academies Press; 2019. https://doi.org/10.17226/25353.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Nebusal.2">
<a name="Nebusal.2"></a>Nebusal 3% (sodium chloride) [prescribing information]. Punta Gorda, FL: PharmaCaribe LLC; September 2010.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Nebusal.1">
<a name="Nebusal.1"></a>Nebusal 6% (sodium chloride) [prescribing information]. Punta Gorda, FL: PharmaCaribe LLC; received June 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33141794">
<a name="33141794"></a>Ong J, Van Gerpen R. Recommendations for management of noncytotoxic vesicant extravasations. <i>J Infus Nurs</i>. 2020;43(6):319-343. doi:10.1097/NAN.0000000000000392<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/33141794/pubmed" id="33141794" target="_blank">33141794</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15542968">
<a name="15542968"></a>Parker MM, Hazelzet JA, Carcillo JA. Pediatric considerations. <i>Crit Care Med</i>. 2004;32(11)(suppl):S591-S594.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/15542968/pubmed" id="15542968" target="_blank">15542968</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28471928">
<a name="28471928"></a>Perez CA, Figueroa SA. Complication rates of 3% hypertonic saline infusion through peripheral intravenous access. <i>J Neurosci Nurs</i>. 2017;49(3):191-195. doi:10.1097/JNN.0000000000000286<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28471928/pubmed" id="28471928" target="_blank">28471928</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22620717">
<a name="22620717"></a>Peterson JD, Goldman MP, Weiss RA, et al. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. <i>Dermatol Surg</i>. 2012;38(8):1322-1330. doi:10.1111/j.1524-4725.2012.02422.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/22620717/pubmed" id="22620717" target="_blank">22620717</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Pulmosal.1">
<a name="Pulmosal.1"></a>Pulmosal 7% (sodium chloride) [prescribing information]. Punta Gorda, FL: PharmaCaribe LLC; November 2013.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Rajajee.1">
<a name="Rajajee.1"></a>Rajajee V. Management of acute moderate and severe traumatic brain injury. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed April 20, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25349312">
<a name="25349312"></a>Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis [published correction appears in <i>Pediatrics</i>. 2015;136(4):782]. <i>Pediatrics</i>. 2014;134(5):e1474-e1502.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/25349312/pubmed" id="25349312" target="_blank">25349312</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31178421">
<a name="31178421"></a>Ratjen F, Davis SD, Stanojevic S, et al; SHIP Study Group. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. <i>Lancet Respir Med</i>. 2019;7(9):802-809. doi:10.1016/S2213-2600(19)30187-0.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/31178421/pubmed" id="31178421" target="_blank">31178421</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28924481">
<a name="28924481"></a>Rawla P, Vellipuram AR, Bandaru SS, Pradeep Raj J. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. <i>Endocrinol Diabetes Metab Case Rep</i>. 2017;2017:17-0081. doi:10.1530/EDM-17-0081<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28924481/pubmed" id="28924481" target="_blank">28924481</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24420913">
<a name="24420913"></a>Reynolds PM, MacLaren R, Mueller SW, Fish DN, Kiser TH. Management of extravasation injuries: a focused evaluation of noncytotoxic medications. <i>Pharmacotherapy</i>. 2014;34(6):617-632. doi:10.1002/phar.1396<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/24420913/pubmed" id="24420913" target="_blank">24420913</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28101605">
<a name="28101605"></a>Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. <i>Intensive Care Med</i>. 2017;43(3):304-377. doi:10.1007/s00134-017-4683-6<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/28101605/pubmed" id="28101605" target="_blank">28101605</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9404379">
<a name="9404379"></a>Robinson M, Hemming AL, Regnis JA, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. <i>Thorax</i>. 1997;52(10):900-903. doi:10.1136/thx.52.10.900<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/9404379/pubmed" id="9404379" target="_blank">9404379</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22610452">
<a name="22610452"></a>Rosenfeld M, Ratjen F, Brumback L, et al. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. <i>JAMA</i>. 2012;307(21):2269-2277.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/22610452/pubmed" id="22610452" target="_blank">22610452</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1991883">
<a name="1991883"></a>Sadick NS. Sclerotherapy of varicose and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter. <i>J Dermatol Surg Oncol.</i> 1991;17(1):65-70. doi:10.1111/j.1524-4725.1991.tb01595.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/1991883/pubmed" id="1991883" target="_blank">1991883</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Saline.1">
<a name="Saline.1"></a>Saline Nasal Spray (sodium chloride) [prescribing information]. Houston, TX: Doc-To-Go LLC; April 2013.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Schmidt.1">
<a name="Schmidt.1"></a>Schmidt GL. Fluids and electrolytes. In Corkins MR, ed. <i>The A.S.P.E.N Pediatric Nutrition Support Core Curriculum</i>. 1st ed. Silver Spring: MD: American Society of Parenteral and Enteral Nutrition, 2010.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Scovell.1">
<a name="Scovell.1"></a>Scovell S. Nonthermal, nontumescent ablation techniques for the treatment of lower extremity superficial venous insufficiency. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed April 20, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27428117">
<a name="27428117"></a>Semler MW, Rice TW. Saline is not the first choice for crystalloid resuscitation fluids. <i>Crit Care Med</i>. 2016;44(8):1541-1544. doi:10.1097/CCM.0000000000001941<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/27428117/pubmed" id="27428117" target="_blank">27428117</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Shane.1">
<a name="Shane.1"></a>Shane E. Treatment of hypercalcemia. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 17, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22470070">
<a name="22470070"></a>Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. <i>Ann Surg</i>. 2012;255(5):821-829. doi:10.1097/SLA.0b013e31825074f5<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/22470070/pubmed" id="22470070" target="_blank">22470070</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26673840">
<a name="26673840"></a>Shein SL, Ferguson NM, Kochanek PM, et al. Effectiveness of pharmacological therapies for intracranial hypertension in children with severe traumatic brain injury--results from an automated data collection system time-synched to drug administration. <i>Pediatr Crit Care Med</i>. 2016;17(3):236-245.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/26673840/pubmed" id="26673840" target="_blank">26673840</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26553190">
<a name="26553190"></a>Silver AH, Esteban-Cruciani N, Azzarone G, et al. 3% Hypertonic Saline Versus Normal Saline in Inpatient Bronchiolitis: A Randomized Controlled Trial. Pediatrics. 2015;136(6):1036-1043. doi:10.1542/peds.2015-1037<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/26553190/pubmed" id="26553190" target="_blank">26553190</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Simply.1">
<a name="Simply.1"></a>Simply Saline Baby Sterile Saline Nasal Mist (sodium chloride) [prescribing information]. Ewing, NJ: Church &amp; Dwight Co Inc; no date.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2222612">
<a name="2222612"></a>Smith EJ, Palevsky S. Salt Poisoning in a Two-Year-Old Child. <i>Am J Emerg Med</i>. 1990;8:571-2.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/2222612/pubmed" id="2222612" target="_blank">2222612</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Westminster.1">
<a name="Westminster.1"></a>Sodium chloride for oral use [prescribing information]. Tampa, FL: Westminster Pharmaceuticals, LLC; received May 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Mylan.1">
<a name="Mylan.1"></a>Sodium chloride inhalation solution 0.9% [prescribing information]. Morgantown, WV: Mylan Pharmaceuticals Inc; December 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Nephron.1">
<a name="Nephron.1"></a>Sodium chloride inhalation solution 0.9% [prescribing information]. Orlando, FL: Nephron Pharmaceuticals; August 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Nephron.2">
<a name="Nephron.2"></a>Sodium chloride inhalation solution 3% [prescribing information]. Orlando, FL: Nephron Pharmaceuticals; December 2011.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ICU.1">
<a name="ICU.1"></a>Sodium chloride 0.9% injection [prescribing information]. Lake Zurich, IL: Fresenius Kabi; May 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Fresenius.1">
<a name="Fresenius.1"></a>Sodium chloride 23.4% injection, USP [prescribing information]. Lake Zurich, IL: Fresenius Kabi; November 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hospira.1">
<a name="Hospira.1"></a>Sodium chloride 14.6% injection, USP [prescribing information]. Lake Forest, IL: Hospira Inc; September 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Westminster.1">
<a name="Westminster.1"></a>Sodium chloride tablets [prescribing information]. Davidson, NC: GenDose Pharmaceuticals; received September 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23266328">
<a name="23266328"></a>Sood L, Sterns RH, Hix JK, Silver SM, Chen L. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. <i>Am J Kidney Dis</i>. 2013;61(4):571-578. doi:10.1053/j.ajkd.2012.11.032<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/23266328/pubmed" id="23266328" target="_blank">23266328</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24569125">
<a name="24569125"></a>Spasovski G, Vanholder R, Allolio B, et al; Hyponatraemia Guideline Development Group. Clinical practice guideline on diagnosis and treatment of hyponatraemia [published correction appears in <i>Eur J Endocrinol</i>. 2014;171(1):X1]. <i>Eur J Endocrinol.</i> 2014;170(3):G1-G47. doi:10.1530/EJE-13-1020<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/24569125/pubmed" id="24569125" target="_blank">24569125</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36938775">
<a name="36938775"></a>Stefanos SS, Kiser TH, MacLaren R, Mueller SW, Reynolds PM. Management of noncytotoxic extravasation injuries: a focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline. <i>Pharmacotherapy</i>. 2023;43(4):321-337. doi:10.1002/phar.2794<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/36938775/pubmed" id="36938775" target="_blank">36938775</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23918113">
<a name="23918113"></a>Sterns RH, Hix JK, Silver SM. Management of hyponatremia in the ICU. <i>Chest</i>. 2013;144(2):672-679.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/23918113/pubmed" id="23918113" target="_blank">23918113</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Sterns.1">
<a name="Sterns.1"></a>Sterns RH. Overview of the treatment of hyponatremia in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed January 17, 2024.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9635664">
<a name="9635664"></a>Suarez JI, Qureshi, AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. <i>Crit Care Med.</i> 1998;26(6):1118-1122. doi:10.1097/00003246-199806000-00038<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/9635664/pubmed" id="9635664" target="_blank">9635664</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10414672">
<a name="10414672"></a>Suarez JI, Qureshi AI, Parekh PD, et al. Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. <i>J Neurosurg Anesthesiol</i>. 1999;11(3):178-184.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/10414672/pubmed" id="10414672" target="_blank">10414672</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17436328">
<a name="17436328"></a>Subbarao P, Balkovec S, Solomon M, et al. Pilot Study of Safety and Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis. <i>Pediatr Pulmonol</i>. 2007;42(5):471-476.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/17436328/pubmed" id="17436328" target="_blank">17436328</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33081526">
<a name="33081526"></a>Topjian AA, Raymond TT, Atkins D, et al. Part 4: Pediatric basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. <i>Circulation</i>. 2020;142(16)(suppl 2):S469-S523. doi:10.1161/CIR.0000000000000901<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/33081526/pubmed" id="33081526" target="_blank">33081526</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12730557">
<a name="12730557"></a>Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage. <i>Stroke.</i> 2003;34(6):1389-1396. doi:10.1161/01.STR.0000071526.45277.44<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/12730557/pubmed" id="12730557" target="_blank">12730557</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25039806">
<a name="25039806"></a>Van De Louw A, Shaffer C, Schaefer E. Early intensive care unit-acquired hypernatremia in severe sepsis patients receiving 0.9% saline fluid resuscitation. <i>Acta Anaesthesiol Scand</i>. 2014;58(8):1007-1014. doi:10.1111/aas.12368<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/25039806/pubmed" id="25039806" target="_blank">25039806</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24074529">
<a name="24074529"></a>Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. <i>Am J Med.</i> 2013;126(10)(suppl 1):S1-S42. doi:10.1016/j.amjmed.2013.07.006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/24074529/pubmed" id="24074529" target="_blank">24074529</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17981159">
<a name="17981159"></a>Verbalis JG, Goldsmith SR, Greenberg A, et al. Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations. <i>Am J Med</i>. 2007;120(11)(suppl 1):1-21.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/17981159/pubmed" id="17981159" target="_blank">17981159</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12794404">
<a name="12794404"></a>Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. <i>Crit Care Med.</i> 2003;31(6):1683-1637. doi:10.1097/01.CCM.0000063268.91710.DF<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/12794404/pubmed" id="12794404" target="_blank">12794404</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Walgreens.1">
<a name="Walgreens.1"></a>Walgreens Sodium Chloride Ophthalmic Ointment 5% Hypertonicity Eye Ointment (sodium chloride) [prescribing information]. Deerfield, IL: Walgreens Co; March 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30397844">
<a name="30397844"></a>Wang J, Fang Y, Ramesh S, et al. Intraosseous administration of 23.4% NaCl for treatment of intracranial hypertension. <i>Neurocrit Care</i>. 2019;30(2):364-371. doi:10.1007/s12028-018-0637-2<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/30397844/pubmed" id="30397844" target="_blank">30397844</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16239885">
<a name="16239885"></a>Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. <i>Neurosurgery.</i> 2005;57(4):727-736.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/16239885/pubmed" id="16239885" target="_blank">16239885</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29900641">
<a name="29900641"></a>Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. <i>Pediatr Diabetes</i>. 2018;19(suppl 27):155-177.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/29900641/pubmed" id="29900641" target="_blank">29900641</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19533046">
<a name="19533046"></a>Woo CH, Rao VA, Sheridan W, Flint AC. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia. <i>Neurocrit Care</i>. 2009;11(2):228-234. doi:10.1007/s12028-009-9238-4<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/19533046/pubmed" id="19533046" target="_blank">19533046</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15805369">
<a name="15805369"></a>Wyckoff MH, Perlman JM, Laptook AR. Use of Volume Expansion During Delivery Room Resuscitation in Near-Term and Term Infants. <i>Pediatrics</i>. 2005;115(4):950-955.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information/abstract-text/15805369/pubmed" id="15805369" target="_blank">15805369</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9929 Version 716.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
